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Short summary  
 
Starch and starch derivatives are widely utilized pharmaceutical excipients, but so far have 
rarely been used for intracellular delivery of nucleotides. The concept of this thesis was to 
make use of starch as a biodegradable backbone and modify it with cationic side chains in 
order to achieve excellent transfection efficiency while maintaining biocompatibility and 
enzymatic biodegradability. A sufficiently controllable, reproducible and efficient side chain 
modification could be achieved via a water soluble intermediate of oxidized starch and an 
optimized protocol using the conjugation reagent, 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-
methyl-morpholinium chloride. Systematic variation of MW fraction of the starch backbone 
and the side chain type, polyethyleneimine (MW = 0.8 kDa), diethylenetriamine, 
tetraethylenepentamine and tris(2-aminoethyl)amine, and amount of cationic side chains (20 – 
35 wt%) yielded a series of cationic starch derivatives. Following purification and chemical 
characterization by GPC, NMR and FT-IR, they were tested for enzymatic degradability by 
alpha amylase. Nano-scale complexes with plasmid DNA could be easily generated and were 
compared to standard 25 kDa branched polyethylene imine polyplexes regarding cytotoxicity 
and transfection efficiency. Some of the synthesized cationic starch derivatives were 
confirmed to show better properties than positive controls, namely, higher transfection 
efficiency, lower cytotoxicity and enzymatic biodegradability. 
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Kurzzusammenfassung 
 
Stärke und Stärkederivate sind weit verbreitete Arzneistoffträger, die bisher kaum für 
Transfektion Verwendung finden. Das Konzept dieser Arbeit war die Verwendung von Stärke 
als biologisch abbaubares Grundgerüst. Durch die Kopplung von kationischen Seitenketten 
wurde eine Transfektionseffizienz erzielt, ohne dabei die Biokompatibilität und enzymatische 
Abbaubarkeit zu verlieren. Eine kontrollierbare, reproduzierbare und effektive 
Seitenkettenmodifikation konnte durch ein wasserlösliches Zwischenprodukt aus oxidierter 
Stärke und ein optimiertes Reaktionsprotokoll erreicht werden. Systematische Variation des 
molekularen Gewichtanteils von Haupt- und Seitenketten, namentlich unterschiedlicher 
Menge an, Polyethylenimin (MW = 0.8 kDa), Diethylentriamin, Tetraethylenpentamin oder 
Tris (2-aminoethyl) amin, sowie die Variation des MWs der Hauptkette lieferte einer Reihe 
von kationischen Stärkederivaten. Die gereinigten und chemisch charakterisierten 
Stärkederivate wurden hinsichtlich ihrer enzymatischen Abbaubarkeit mittels α-Amylase 
untersucht. Nanoskalige Komplexe mit Plasmid-DNA wurden hergestellt und mit 25 kDa 
Polyethylenimin Polyplexen hinsichtlich Zytotoxizität und Transfektionseffizienz verglichen. 
Einige der synthetisierten kationischen Stärkederivate zeigten bessere Eigenschaften im 
Vergleich zur Positivkontrolle, da sie höhere Transfektionseffektivität, geringere Zytotoxizität 
und zusätzlich enzymatische und hydrolytische Abbaubarkeit aufwiesen. 
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1.1 Gene delivery 
 
The therapeutic possibilities of nucleotide drugs in the last two decades expanded notably. 
Nucleotides as drugs have some advantages in comparison to peptides/proteins. They are 
comparatively easy to produce. From the delivery point of view they are all quite similar 
molecules. This allows transferring the know-how and knowledge from one delivery system 
for a special siRNA or pDNA on others or even a mixture of several sequences
1
. In 
consequence a rather universal delivery platform for nucleotides should be easier feasible, 
while proteins differ in size and properties to an extent that favors tailored carrier synthesis. A 
view of gene therapy trials conducted so far show a majority of viral vectors. However, in 
research a shift toward non-viral delivery is apparent and numerous polymeric or lipid carriers 
have been developed. The report “Drug Delivery Technologies: Players, products & prospects 
to 2018”2 sees significant opportunities for future commercial development, in particular the 
development of new polymers and biopolymers as carriers, the development of targeting 
strategies and the identification and delivery of polygenic genes in order to allow therapies of 
multi-gene based diseases. The key is an effective transport inside target cells and a controlled 
release at the target point. However, the history of gene delivery research evidences the high 
complexity factor of this task. 
The plain nucleotide itself could not achieve the effective gene delivery due to the large 
molecular size, high negative charge and the prone to enzymatic degradation. Therefore, the 
ideal gene delivery vector should be able to bind and condense nucleotides molecules, 
neutralize the negative charges, provide a protection against the degradation. Besides, it 
should facilitate the cellular uptake, escape from endosome/lysosome into the cytoplasm, and 
in case of pDNA further transfer to the nucleus for the following transcription and translation. 
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1.1.1 Gene delivery pathway into the cells 
In the development of gene delivery vector, the pathway of the delivery system should be 
always taken into account. The transgene/vector complex should overcome multiple barriers 
during the pathway and this is the first obstacle to solve. Further modifications or formulation 
strategies of transgene/vector complex to reach the target could be firstly undertaken after the 
successful cross of these barriers. In Figure 1, DNA delivery pathway is schematically shown 
and the important steps are briefly explained in the following section. 
 
 
 
Figure 1: Gene (DNA) delivery pathways by non-viral vector 
 
1) DNA/vector complex formation 
There are three main purposes of the DNA complexation with a vector i) neutralization or 
masking of negatively charged DNA, ii) compaction of the large sized DNA and iii) 
protection of DNA from extra- and intracellular degradation (pH-dependent and 
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enzymatically). Most of the non-viral vectors have positive charges to make an 
electrostatic interaction with the negatively charged phosphate groups of DNA. These 
positive charges could neutralize the negatively charged DNA, and normally, complexes 
are formulated with a slight excess of positive charges to enhance the interaction with 
negatively charged cell surface. The size of the complexes can be also controlled 
depending on the vector type and cationic-anionic charge ratio. The size variations from 
20 nm to 2 µm of the complexes were reported
3, 4
.  
 
2) Cellular uptake 
Cellular uptake of DNA/vector complex is generally separated endocytotic- and non-
endocytotic pathway (e.g. permeabilization, electroporation, fusion, penetration). However, 
the intensive studies of the cellular uptake exhibited that it mainly occurred by endocytotic 
pathways
5, 6, 7
. Thereby the resent focus is more on which endocytotic pathways various 
complexes can take and what complex properties are key to guide. There are two broad 
classes of endocytotic pathyways, phagocytosis, which involves the uptake of large 
particles (> 0.5 µm), and pinocytosis, which involves the uptake of fluid and solutes 
(Figure 2
8
).  
 
Phagocytosis 
Phagocytosis is an active and well regulated procedure that involves specific cell surface 
receptors and signaling cascades. It takes place in specific cells, such as macrophages, 
monocytes and neutrophils, which have a function to eliminate large pathogens (e.g. 
bacteria, parasites and large cell debris). Some viruses and miniviruses are known to use 
phagocytosis to enter cells
9, 10
. 
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Pinocytosis 
Major pinocytotic pathways with different morphological characteristics are introduced 
here:  macropinocytosis, clathrin-mediated, caveolae-mediated, and clathrin/caveolae-
independent endocytosis
8
 and are also depicted in Figure 2. Macropinocytosis can be 
defined as a formation of primary large endocytotic vesicles of irregular size (< 5 µm) and 
shape, generated by actin-driven invaginations of the plasma membrane
11
. Since the sizes 
of macropinosomes are larger than other pinocytotic endosomes, macropinocytosis is 
regarded as an efficient route for the nonselective endocytosis of solute macromolecules. 
Clathrin-mediated endocytosis (CME), previously known as receptor-mediated 
endocytosis, is the major and best-characterized endocytotic pathway
12, 13
. The first step of 
internalization through CME is the strong binding of a ligand (e.g. transferrin, antibodies, 
low density of lipoprotein) to a specific cell surface receptor. This produces the clustering 
of the ligand-receptor complexes in coated pits on the plasma membrane, which is formed 
by the assembly of cytosolic coat proteins, the main assembly units being clathrin. 
Following, the coated pits invaginate and pinch off from the plasma membrane to form 
intracellular clathrin-coated vesicles (100 -150 nm in diameter), which would become the 
early endosome. Caveolae-mediated endocytosis; Caveolae are invaginated, flask-shaped 
pits (around 50 nm) of plasma membrane, which are especially enriched in cholesterol and 
sphingolipids. They are characterized by the presence of the integral membrane protein 
cavoelin. Though the pits are quite small, caveolae can internalize large molecular 
complexes, such as cholera toxin, and may serve as a portal of entry for certain viruses 
and bacteria. In this way, the internalized materials in caveolin coated vesicles could 
escape the delivery to lysosomes and digestion. Thus, caveolae-mediated endocytotic 
pathway could be advantageous in drug and gene delivery systems, as well as clathrin-
mediated endocytotic pathway. Clathrin/Caveolae-independent endocytosis does not use 
a clathrin or caveolin coated vesicles, was reported by several researchers
14, 15
. These 
pathways should be further studied and defined by their dependency to various molecules 
such as cholesterol, small GTPases or tyrosine kinase. 
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Figure 2: Different endocytotic pathways, modified from ref
8
 
 
 
3) Endosomal escape 
After the internalization through the endocytosis, the internalized molecules exist in 
endosomes and physically have no contact with cytosol or nucleus. These endosomes 
would either fuse with lysosomes for degradation or recycle their contents back to the cell 
surface. Therefore, the internalized complexes should escape from endosomes in time to 
exert their intended function. In the following, different procedures of endosomal escape 
are briefly introduced.  
 
Pore formation 
Basically, the pore formation in the endosomal lipid bilayer is mediated by a membrane 
tension that enlarges the pore, that caused by compounds which have high affinity to the 
rim of the pore. It has been shown that some cationic peptides could sufficiently bind the 
lipid bilayer and create pores
16
.  
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Proton sponge effect
17
 (pH-Buffering effect) 
The proton sponge effect is mediated by vectors with high buffering capacity. With the 
decreasing endosomal pH to approximately 5.4, the protonation of the entrapped agents 
induces an extensive inflow of ions and water into the endosome. This would increase the 
osmotic pressure in the endosome. Subsequently, disruption of the endosomal membrane 
would be induced and entrapped materials would be released. The compounds with 
multiple amine groups, such as polyethyleneimine (PEI) and poly(amido amine)s,  are 
known to show proton sponge effect because of their high buffering capacity.  
 
Membrane fusion 
Endosomal escape through the membrane fusion could only occur when the DNA is 
enveloped by a membrane (e.g. cationic liposomes). The fusion of the carrier membrane 
with the endosomal membrane could result in the escape of the nucleotides into the 
cytosol. A helper reagent, such as cholesterol
18
, is sometimes incorporated into the 
liposomal particles to enhance the fusogenicity of the membranes.  
 
Photochemical internalization (PCI) 
PCI is a relatively new technology
19, 20
 to release the endosomal entrapped compounds into 
cytoplasm by light-induced activation of endosomal localized photosensitizers (e.g. 
disulfonated aluminium phthalocyanine, meso-tetraphenylprophine with two sulfonate 
groups). The activated photosensitizers could induce photodynamic reactions which 
results in the destruction of the endosomal membrane mediated by reactive oxygen species. 
A number of successful gene delivery approaches was reported using this technology by 
incorporating photosensitizers into the transgene/vector complex
21, 22, 23
. Kloeckner et al.
22
 
established the PCI using PEI based polyplexes, and Nishiyama et al.
23
 incorporated 
photosensitizers into dendrimer matrix and demonstrated the light-responsive 
supramolecular gene delivery. 
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4) Nuclear transport 
In the nuclear membrane, there are small pores with a passive transport limit of 70 kDa of 
MW or 10 nm diameters. However DNA is much bigger than these pores even condensed 
by any vectors and simple passive transport through these pores would be difficult.  In 
vitro, the most accepted nuclear transport mechanism is cell division. During the mitosis, 
the integrity of the nuclear membrane is temporary lost, which enables DNA (complexes) 
to enter the nucleus. As cell culture cells are often fast proliferating this step might be 
underestimated. Thus, in vivo, additional different mechanism have been suggested. It is 
known that many proteins are actively transported to the nucleus because of the presence 
of nuclear localization signals, which are short cationic peptide sequences that are 
recognized by importins
24
. Since many of the DNA/vector complexes have cationic 
charges, it has been considered that a similar mechanism could be used to enhance DNA 
(complex) transport into the nucleus.  
 
5) Dissociation of DNA from vector 
The DNA/vector complex should be dissociated either before or after the transport into the 
nucleus to enable transcription. In the ideal case the binding between vector and DNA 
should be broken and DNA released in the nucleus where the enzymatic protection is not 
needed any more. Still the binding strength should be controlled to keep the enable fast 
and efficient rules needed to achieve the successful translation. 
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1.2 Non-viral gene delivery vectors 
 
The advantages and disadvantages of viral and non-viral gene delivery vectors have been often 
discussed in the history of gene delivery vector development. Viral vectors include viruses 
(e.g. retrovirus, adenovirus, adeno-associated virus), and generally they are very efficient gene 
delivery vectors. However fatal drawbacks limited their practical use. Viral vectors may elicit 
mutagenesis and carcinogenesis. Additionally, the repeated administration of viral vectors 
could induce an immune response which abolishes the transgene expression
25
. Therefore, 
researches are more and more shifted toward the non-viral vectors. Since the non-viral vectors 
are still rather inefficient in transfection, the recent researches generally focus on the 
improvement of the transfection efficiency, at the same time, retaining the advantages of non-
viral vectors, being non-pathogenic and non-immunogenic. 
 
1.2.1 Different types of non-viral gene delivery vectors 
A large number of non-viral gene delivery vectors have been studied.  In Table 1, different 
types of non-viral gene delivery vectors were summarized and are briefly explained in the 
following.  
 
1.2.1.1 Ceramic based vectors 
The successful gene deliveries were reported using ceramic based non-viral gene delivery 
vectors
26, 27, 28
. Silica (SiO2), hydroxyapatite, zirconia (ZrO2) and their modified materials are 
often studied. Mostaghaci et al.
28
 synthesized amino-functionalized calcium phosphate 
nanoparticles and reported the successful pDNA transfection with negligible cytotoxicity. 
Generally, the advantages of the ceramic based vectors are the ease of the preparation, 
monodispersity of the vector and their water dispersability. On the other hand, the surface 
adsorption of the transgene instead of encapsulation could be a disadvantage, which may not 
effectively enough protect the nucleotides from degradation. 
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1.2.1.2 Metal based vectors 
Gold, iron oxide, zinc oxide and their modified nanoparticles can be given as examples of the 
metal based gene delivery vectors
29, 30, 31
.  The biggest advantage of the metal based vectors is 
the small and uniform particle size, less than 50 nm, which enlarge the surface area for the 
transgene - adsorption. Additionally, it is shown that superparamagnetic iron oxide 
nanoparticles provide a huge benefit as magnetic resonance imaging (MRI) contrast agents
32
. 
The availability of a universal MR marker to image gene expression is especially important to 
follow the delivery system and know where the transfection takes place. As such, iron oxide 
nanoparticle could confer a big opportunity. The disadvantage of metal based vectors would 
be, same as ceramic based vectors, surface adsorption of transgenes instead of encapsulation 
and also the toxicity of the materials.  
 
 
Table 1: Different types of non-viral gene delivery vectors 
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1.2.1.3 Liposome based vectors 
A solution of cationic lipids is mixed with genes to form a positively charged complex, named 
lipoplex. Widely used commercial cationic lipids for gene delivery application are N-(1-(2,3-
dioleyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTMA), 1,2-bis(oleoyloxy)-3-
(trimethylammonio)propane (DOTAP), 3β(N-(N,N-dimethylaminoethane)-carbamoyl) 
cholesterol (DCChol), and dioctadecylamidoglycylspermine (DOGS)
33
. A natural lipid, 
Dioleoylphosphatidylethanolamine (DOPE), is often used with cationic lipids for the 
membrane destabilization at low pH intended for endosomal escape. The advantages of 
lipoplex are lack of immune response, low cost and diverse range of morphologies. As 
disadvantages, lack of colloidal stability and leakage of encapsulated transgenes are often 
mentioned. 
 
1.2.1.4 Carbon assemblies based vectors 
Carbon assemblies are a relatively new class of gene delivery vectors, such as carbon 
nanotubes (CNTs), fullerenes (C60) (Figure 3), nanodiamonds based materials
34, 35, 36, 37
.  
 
 
                   CNT                                                  fullerene 
Figure 3: Structures of CNT and fullerene 
 
Especially carbon nanotubes are intensively studied in last two decades
38, 39
, not only in 
biomedical field but also many other field, such as sensing, material science, electronics, 
optics and gas storage etc. Cationic-functionalized CNTs are usually used to condensate the 
polynucleotides. CNTs own interesting structural, optical and electrical properties for drug and 
gene delivery system. The large surface area allows multi-functionalization of various 
Introduction   
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molecules to get suitable properties as gene delivery vectors and a number of successful gene 
deliveries were reported by using functionalized CNTs as vectors
40, 41, 42
. The disadvantage of 
the carbon assemblies would be the poor solubility in biological solution. 
 
1.2.1.5 Polymer based vectors 
Usually, positively charged complexes, so called polyplexes, are generated simply by mixing 
of the polymer solution with the transgene in an optimized ratio. This simple production 
without the need of complex processes or solvents is an advantage of such delivery systems. 
The cationic net charge and the impact of pH and ionic strength on the complex stability, 
however, are topics to be considered when such delivery systems aim for translation in vivo.  
Thus, not only polymers from various monomers but also many derivatives were synthesized 
in order to optimize their properties. Polymers are diverse vectors with respect to chemical 
components, as well as structures, e.g. linear polymers, branched polymers, homopolymers, 
di-, tri- block/random copolymers. More details of the major polymers in the use of gene 
delivery vectors are explained in the following section (1.2.2). 
 
 
1.2.2 Most frequently used polymers in gene delivery 
The first application of polymers as non-viral gene delivery vector was in 1965 by Vaheri and 
Pagano
43
. They used diethylaminoethyl functionalized dextran. Since then, a large number of 
polymers with different chemical structures and characteristics has been developed and 
studied for their ability as gene delivery vectors.  
Regarding the chemical composition, polymers could be separated in synthetic and natural 
polymers. An advantage of the synthetic polymers is their potential for high reproducibility 
and homogeneity. The natural polymers on the other hand profit from their natural abundance 
and biodegradability. Within the group of synthetic polymers PEI and Poly(2-
(dimethylamino)ethyl methacrylate) (pDMAEMA) are the most prominent vector for gene 
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delivery. As natural polymers, poly(L-lysine) (PLL) and different carbohydrates are often 
studied as gene delivery vector. In the following sections, some of the most studied and 
focused polymers are categorized and briefly explained. 
 
1.2.2.1 PEI 
Since the first successful PEI mediated oligonucleotide transfer presented by Boussif et al.
44
, 
PEI has been recognized as the gold standard polymer for gene transfection. The chemical 
structure of PEI contains nitrogen at every third atom, which results in a high cationic charge 
density. At a physiological pH, ca. 80 % of amine groups are unpronated, while less than 50 % 
amine groups are unprotonated at pH 5. This buffering capacity is the driving force to escape 
from the endosome (proton sponge effect), and this special feature is accepted as a one of the 
main reason of the high transfection efficiency of PEI. PEI exists as a branched structure, 
branched-PEI (b-PEI), and linear structure, linear-PEI (l-PEI) (Figure 4), and they showed 
different properties as gene delivery vectors. The degree of branching has been shown to have 
an influence to the polyplex formation and stability. Dunlap et al.
45
 showed that l-PEI is less 
effective to condensate DNA compared to the similar MW b-PEI. Additionally, the more 
primary amine groups PEI has, the more stable polyplex were obtained. That makes b-PEI 
more suitable transfection vector than l-PEI
46
. 
 
 
              b-PEI                                                                   l-PEI 
Figure 4: Two structures of PEI: b-PEI and l-PEI 
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The MW of the PEI is also known to have an effect on the transfection efficiency. Godbey et 
al.
47
 showed that larger MW PEI could showed higher transfection efficiency in the range of 
600 to 70 kDa, though the larger MW PEI showed the higher cytotoxicity
48
. In spite of its high 
ability to transfect oligo- and polynucleotides, PEI has critical drawbacks, cytotoxicity and 
non-biodegradability. Various groups have been working on the topic to overcome theese 
drawbacks. One of the most popular ways to reduce cytotoxicity is PEGylation
49, 50, 51, 52, 53
. 
Non-toxic and non-charged PEG could neutralize the positive surface charge of PEI, and result 
in a reduction of cytotoxicity. Linking small MW PEI with biodegradable chemical structure, 
such as disulfide and hydrolysable ester linkages has been studied to achieve a “biodegradable” 
PEI
54, 55, 56, 57, 58
.  
 
1.2.2.2 Poly(L-lysine) (PLL) 
 
 
Figure 5: Chemical structure of PLL 
 
PLL was recognized as a gene delivery vector since Laemmli et al. found its ability of gene 
condensation in 1975
59
. PLL, as well as PEI, contains amine groups in its structure and this 
primary amine groups could effectively condensate the oligo- and polynucleotide. Unlike PEI, 
all amine groups of PLL are protonated at physiological pH, resulting in the structure with no 
buggering capacity
60
 to guide to endosomal escape. With the addition of chloroquine or 
membrane-active peptide, the endosomal escape was shown to be improved
61
. In general, PLL 
with MW > 3000 Da could effectively condense DNA to form stable polyplexes, though this 
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MW PLL showed relatively high cytotoxicity
62
. To overcome this cytotoxicity, several PLL 
derivates were synthesized containing biodegradable linkage, such as disulfide or hydrolysable 
ester functions. For instance, biodegradable poly(lactid-co-glycolid) acid (PLGA)-grafted PLL 
conjugates showed reduced cytotoxicity and the same level of transfection efficiency 
compared  to PLL
63
. Another disadvantage of PLL/DNA polyplex is the tendency to aggregate 
and precipitate in the ionic biological solution. Conjugation with PEG and synthesize a PLL-
PEG block copolymer is a common solution to avoid this aggregation and precipitation
64, 65
. 
Fukushima et al. additionally added poly((3-morpholinopropyl) aspartamide) chain to PLL-
PEG and synthesized triblock copolymer
65
. This triblock copolymer showed improved 
buffering capacity and transfection efficiency compared to PLL-PEG. 
 
1.2.2.3 Poly(2-(dimethylamino)ethyl methacrylate) (pDMAEMA) 
 
 
DMAEMA monomer 
 
     pDMAEMA 
 
Figure 6: Chemical structure of DMAEMA and pDMAEMA 
 
pDMAEMA is a polymethacrylate synthesized via radical polymerization of 2-
(dimethylamino) ethyl methacrylate monomer (DMAEMA) (Figure 6). Since pDMAEMA has 
cationic charges in its repeating units, it shows good properties as gene delivery vector. The 
high potential of pDMAEMA as transfection reagent was reporter first in 1996 by Cherng et 
al.
66
, with a 90 % efficiency compared to b-PEI 25 kDa. Since then pDMAEMA and its 
copolymers have been intensively studied. pDMAEMA with MW > 112 kDa is known to 
make small and stable polyplex and show efficient transfection, but at the same time, certain 
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cytotoxicity. To reduce the cytotoxicity without decreasing the transfection efficiency, the 
modification of pDMAEMA was studied. Also with pDMAEMA the PEGylation was studied 
and a pDMAEMA-PEG diblock copolymer was synthesized. The cytotoxicity of the 
pDMAEMA-PEG was improved, though the transfection was decreased
67
. Incorporation of 
hydrophobic block (polycarprolactone (PCL)) between pDMAEMA and PEG block, resulted 
in pDMAEMA-PCL-PEG triblock copolymer, showed 15 times higher transfection than 
pDMAEMA-PEG
68
. Another method is copolymerization with other hydrophobic or 
hydrophilic monomers with DMAEMA. Van de Wetering et al.
69
 copolymerized N-
vinylpyrrolidone (NVP) with DMAEMA, and found  an increased transfection efficiency  of 
the pDMAEMA-pNVP copolymer. Due to the improved technology of living radical 
polymerization, such as atom transfer radical polymerization (ATRP) and reversible addition 
fragmentation chain transfer (RAFT) polymerization, the pDMAEMA based gene delivery 
vector was further developed and investigated. Biodegradable pDMAEMA is one of the 
focused research area. Jiang et al.
70
 synthesized biodegradable brush shaped copolymers 
composed from biodegradable poly(hydroxyethyl methacrylate) (pHEMA) backbone and 
pDMAEMA side chains via ATRP. The synthesized pHEMA-graft-pDMAEMA copolymer 
brush was shown to have lower cytotoxicity and higher transfection efficiency than high MW 
(MW > 300 kDa) pDMAEMA homopolymer.  
 
1.2.2.4 Dendrimer structured polymers 
Dendrimers are well-defined chemical structures, which are composed of many branches and 
subbranches systematically radiating out from a central core (Figure 7).  These unique 
molecular architectures provide interesting properties for the development of gene delivery 
vector, such as defined architecture and high ratio of multivalent surface moieties to molecular 
volume. 
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Figure 7: Schematic structure of a dendrimer.  
 
Because of the ease of synthesis and commercial availability, polyamidoamine (PAMAM) 
dendrimers have been the most utilized dendrimer based gene delivery vector. Due to the large 
number of secondary and tertiary amines on the polymer, PAMAM based polyplex show a 
proton sponge effect, helping them to escape from endosomes. Haensler and Szoka
71
 reported 
that the sixth-generation PAMAM dendrimer showed the best properties within  several other 
generation PAMAM dendrimers as gene delivery vector. “Generation” refers to the number of 
repeated branching units during the synthesis of dendrimers. The higher generation dendrimers 
have the more functional groups on the surface, which could show huge impact on the 
cytotoxicity and transfection efficiency. Except PAMAM, some amine functional polymers, 
such as Poly(propylenimine) (PPI) and PLL dendrimers are also investigated for gene 
transfection
72
. The possibility of multi-functionalization of the dendrimer surface was the most 
studied way to improve the transfection and lower the cytotoxicity.  
 
1.2.2.5 Carbohydrate-based polymers 
Carbohydrate-based polymers have been also investigated as gene delivery vectors
73
. In 
general, they have considerable advantages, such as a lack of toxicity and absence of 
antigenicity and immunogenicity. Some examples of intensively studied polymers are chitosan, 
hyaluronic acid, dextran and cyclodextrin-based polymers (Figure 8). Among them, chitosan is 
the most investigated polymer
74, 75, 76 
, because of its originated cationic charges in the structure. 
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Similar to the polymers introduced before, the MW of chitosan could give an impact to 
transfection efficiency. Huang et al.
77
 demonstrated that with increasing MW of chitosan, the 
transfection efficiency was increased (213 kDa > 98 kDa > 48 kDa > 17 kDa). The 
deacetylation amount of chitosan is also important. Generally, increasing deacetylation 
amount improves transfection efficiency in vitro for various cell lines
78
, though moderate 
deacetylation chitosan showed the best transfection efficiency in vivo
77
. These results 
emphasized the importance of optimal balance between protection/condensation of the DNA 
and facile release of DNA from the vectors. To improve the buffering capacity, chitosan 
modification with PEI and urocianic acid, which results in an imidazole containing chitosan, is 
often used
79, 80
. Both modifications could successfully improve the buffering capacity and 
resulted in the higher transfection efficiency. Since other polymers, hyaluronic acid, dextran 
and cyclodextrin do not have cationic charges, these polymers were often used after 
modification with cationic charges. Dandekar et al.
81
 reported cationic polyrotaxane 
synthesized from cationic modified cyclodextrin and cationic axis used for the successful 
siRNA delivery. Cui et al.
82
 modified dextran with various amine functionalized molecules 
and synthesized biodegradable cationic dextran derivatives and reported successful siRNA 
delivery. 
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(b)    
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Figure 8: Structures of carbohydrate-based polymers 
(a) chitosan, (b) hyaluronic acid, (c) cyclodextrin,  (d) dextran 
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1.3 Starch 
 
Starch is abundantly generated in nature as the main storage polysaccharide in higher plants. It 
exists as granules in the chloroplast of green leaves and the amyloplast of seeds, pulses and 
tubers
83
. From the chemical point of view, starches consist of two major components, amylose 
(10-25%) and amylopectin (75-90%). Both of them are polysaccharides from a number of 
glucose molecules linked together. The differences between them are the way of glucose 
linkages and the final structure, namely branching or no-branching. Amylose is a linear 
polysaccharide which glucose residues are alpha-1,4-linked, and the degree of polymerization 
is up to 6000. The amylose can easily form single or double helices, and is soluble in hot water.  
Amylopectin is a branched polysaccharide which glucose residues are alpha-1,4- and alpha-
1,6- (5 %) linked, and the average degree of polymerization is, much higher than amylose, two 
million, thereby being one of the largest molecules in nature. Typical amylopectin has 20 to 25 
glucose units between branching points. They are more difficult to solubilize than amylose, 
even in hot water. The chemical structures of amylose and amylopectin are shown in Figure 9. 
 
 
 
          Amylose                                                                Amylopectin 
Figure 9: Chemical structures of amylose and amylopectin 
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1.3.1 Uses of starch 
The biggest advantages of starch are the environmental acceptability, biocompatibility and 
biodegradability. Starch is a renewable raw material with huge prospectiveness, since the 
modification of starch could alter the characteristics of starch and give an additional value. 
Therefore, starches and modified starches are used for a wide range of products in different 
applications
84
 (Table 2). The biggest consumers of non-food starch might be the paper and 
cardboard industry
85
. Starch and modified starches are used in the different processes in the 
production of paper and cardboard, not only as binders but also for the improvement of the 
product properties. For instance, the use of cationic starch can improve the mechanical 
strength of the resulting paper sheet
86
.  
 
Table 2: Industrial use of starch and modified starch
87
 
 
 
Additionally, starches are used as adhesives, detergents, and also thermoplastics. With the 
increasing needs and interests of environmental friendly products especially in food packaging 
industry, biodegradable thermoplastics/packaging materials are focused a lot
88
. López et al.
89
 
developed a starch based film for food packaging with a good heat sealing capacity. The high 
value-added applications of starch would be seen in cosmetic, medical and pharmaceutical 
industries. The use of starch for pharmaceutical application has been changed in the last few 
decades, with the emergence of drug delivery concept. High value-added starches could play a 
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cardinal role as substrate for tissue engineering
90
 and as drug carriers.  As such, their value is 
not the same anymore as simple diluents or binders.  
 
1.3.2 Applications of starch derivatives in drug delivery and gene delivery 
Recently an increasing number of researches is reported that applies starch derivatives in drug 
delivery. Starch was modified with different functional groups or polymers to improve its 
properties as a delivery vector. Micro- and nano sized particles, capsules and complexes of the 
drug and starch derivatives have been shown to possess high potential to overcome biological 
barriers and lead to successful drug delivery.  
Balmayor et al.
91
 presented biodegradable starch-poly-ε-caprolactone microparticles sized 5 to 
900 µm as a drug delivery system for dexamethasone as a model drug. Different surface 
morphology (smooth and porous) was observed in the different formulations. The formulated 
microparticles showed excellent encapsulation efficiency up to 93 % and a reasonable release 
profiles, which would correspond to the degradation of the polymer. 
Santander-Ortega et al.
92
 used hydrophobic propyl-starches and form nanoparticles in a size 
range of 150 to 200 nm for transdermal drug delivery. These starch based nanoparticles could 
encapsulate a wide range of chemically different drugs (flufenamic acid, testosterone and 
caffeine) with a good efficiency, and showed a prominent enhancement of skin penetration for 
the flufenamic acid formulation.  
Baier et al.
93
 synthesized nanocarriers (170 to 300 nm) from crosslinked hydroxyethyl starch. 
The modification of the nanocarriers surface with folic acid dramatically increased the specific 
cellular uptake into HeLa cells. These results demonstrated a high potential of receptor-
mediated targeting using starch based nanocarriers. 
Zhang et al.
94
 synthesized pH-responsible smart starch-graft-poly(L-glumamic acid) 
copolymer by click reaction. Their formulated starch-graft-poly(L-glumamic acid)  
nanoparticles changed their sizes depending on the pH, and proofed such an excellent pH-
responsive property. Additionally, the insulin release profile was studied at different pH values. 
They showed that the insulin release was slower in low pH condition (artificial gastric juice, 
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pH = 1.2) than at higher pH condition (artificial intestinal liquid, pH = 6.8). These results 
indicated that these pH-responsible nanoparticles could protect the insulin in a gastric 
environment and prevent enzymatic degradation, followed by a controlled drug release in the 
intestine. 
 
Through the increasing number of research regarding starch based vectors in drug delivery 
application, only two studies were found that worked on gene delivery and both were from 
same research group by Noga et al.
95, 96
. Hydroxyethyl starch (HES) instead of gold standard 
PEG, was used to shield the cationic charge of the DNA/l-PEI (22 kDa) polyplexes. Different 
from PEGylation, HESylation could be unshielded through the degradation of HES by the 
addition of α-amylase which leads to anincreased uptake of the polyplexes into the target cells. 
Their first paper
95
 presented the increased transfection efficiency of HESylated PEI by the 
addition of α-amylase, though it was not the case for PEGylated PEI. In their second report96, 
the optimal MW of HES and degree of HESylation were studied and the importance of the 
fine balance of these parameters became clear. The higher MW of HES could shield the 
cationic charges of polyplexes better. More hydroxymethyl groups on the starch reduced the 
biodegradability by α-amylase and leaded decreased transfection efficiency. In conclusion, 
HES with 70 kDa MW and 50 % hydroxyethyl groups against glucose unit showed the best 
results in an in vivo study. The large MW (70 kDa) HES effectively shielded the cationic 
charge of polyplexes and improved the stability, and the biodegradability of the shell at the 
same time allowed the same level of luciferase transfection efficiency in comparison to no-
HESylated l-PEI (22 kDa), though it was not the case for PEGylated PEI. 
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2 Aim of this work 
 
The main motivation of this thesis was to design and synthesize novel starch based polymers 
as a gene delivery vector which could achieve high transfection efficiency and safety. Though 
starch and starch derivatives are widely utilized pharmaceutical excipients, but so far have 
rarely been used for intracellular delivery of nucleotides. The concept of this study was to 
make use of starch as a biodegradable backbone and to modify it with different cationic side 
chains in order to achieve better transfection efficiency while maintaining biocompatibility 
and enzymatic biodegradability. 
The major aims of this thesis were: 
1) To establish the optimal reaction method of the starch and PEI conjugates as a suitable gene 
delivery vector (chapter 3). 
2) To evaluate the synthesized starch and PEI conjugates as gene delivery vectors, focusing on 
the transfection efficiency and safety, and find out the specific characteristics of the polymer 
for the successful gene delivery (chapter 4). 
3) To study the effect of the additional hydrophobic chains on the starch and PEI conjugates 
(chapter 5). 
4) To study the effect of different cationic side chains (MW and structure) instead of PEI 
(chapter 6).  
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3.1 Introduction 
The use of cationic polymers is well established in the gene delivery field
97
 due to their 
capability to condense nucleic acids into compact polyplexes and thus protect them from 
degradation. The cationic charge of such polyplexes facilitates their cell surface attachment 
and endocytotic uptake, while their pH buffering capacity (known as the “proton sponge 
effect
17”) may allow for the possibility of endosomal escape. However, cationic polymers also 
have a crucial drawback, which is a high level of cytotoxicity. Therefore the amount and 
density of cationic charges in the polymer needs to be precisely controlled through careful 
polymer design, in order to maintain a balance between safety and successful gene delivery. A 
variety of cationic polymers including polyethylenimine, poly(dimethylaminoethyl 
methacrylate)
98,99
, and chitosan
74, 75, 76
 have been studied as gene delivery vectors. Branched-
polyethylenimine (b-PEI, 25 kDa), a well-known cationic polymer often employed as a gene 
delivery vector, shows excellent transfection efficiency and is regarded as a “gold standard44” 
among polymers. However, b-PEI is also known to show certain cytotoxicity
100
. Many studies 
have therefore been conducted to develop improved PEI-based polymers which retain a high 
level of transfection efficiency, but exhibit a lower cytotoxicity. The shielding of cationic 
charges on the PEI surface with polyethylene glycol, so called “PEGylation”, is one of the 
methods employed to reduce polymer cytotoxicity
49,50,51,52,53
. Petersen et al.
49
 reported that 
PEGylated b-PEI showed lower cytotoxicity than b-PEI, and found the optimum PEG chain 
molecular weight (MW) and amount of b-PEI modification. Another drawback of PEI is its 
non-biodegradability. To overcome this obstacle, crosslinking of the low MW PEI with a 
biodegradable cross-linker has often been performed
54, 55, 56, 57, 58
. For example Gosselin et al.
54
 
cross-linked low MW PEI (0.8 kDa) with disulfide bonds in order to synthesize biodegradable 
b-PEI. These disulfide bonds can be cleaved by reducing agents like glutathione, but not by 
enzymes. The transfection efficiency of b-PEI cross-linked in this manner was not superior to 
b-PEI 25 kDa, however it was shown the advantages of a lower cytotoxicity and an improved 
degradability due to reduction of disulfide bonds was achieved. 
Synthesis of the Starch-graft-PEI polymers   
29 
Several polysaccharide-based polymers have been studied as gene delivery vectors, mainly 
chitosan
74, 75, 76
 and hyaluronic acid
101, 102
. Less of a focus has been placed to date on starch. 
Polysaccharides in general have considerable advantages for use as gene delivery vectors, 
including a lack of toxicity and absence of antigenicity and immunogenicity.   
In this work, we propose the novel design of a well-defined and possibly biodegradable 
cationic copolymer composed of water-soluble potato starch and low MW PEI (s-PEI, 0.8 
kDa). Starch is a biocompatible and biodegradable polymer, generated abundantly in nature as 
the main storage polysaccharide in higher plants. Starch, compared with other polysaccharides, 
has the additional advantages of a high cost performance and biodegradability not only by 
hydrolysis, but also by human enzymes, particularly α-amylase. It is well-known that α-
amylase is found in the saliva, pancreatic juices, blood and urine. Some amounts of 
polysaccharides, including starch, are known to be degraded intracellularly by various 
enzymes
103, 104, 105
. In addition, the existence of amylase-producing tumors has been 
reported
106,107, which could be also a good target for α-amylase degradable starch-based 
delivery systems. As a further advantage, the OH groups of the glucose units of starch offer 
plenty of possibilities for functional substitution. The properties of the modified starch can 
therefore be greatly altered depending on the substitution groups and degree of substitution.  
However, the modification of the glucose units of starch with larger or complex molecules is 
not an easy task because of the steric inaccessibility of the molecules to the reaction site of the 
starch. Therefore, no direct conjugation of PEI to a starch backbone was published so far. The 
researchers are using already modified starch (e.g. Hydroxyethyl starch
95
) and PEI, or opening 
the glucose ring and make the dialdehyde starch
108
 to react with PEI. Zhou et al.
109
 modified 
amylopectin in a conjugation with small cationic molecules and studied the transfection 
efficiency. Since the cationic side chains (consisting of ethylenediamine, diethylenetriamine 
and 3-(dimethylamino)-1-propylamine) of the produced modified amylopectins were quite 
small, it was deemed necessary to modify almost all OH groups of each glucose unit to get 
good transfection efficiency. While it was not investigated, such extensive modification could 
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potentially have led to a loss of the enzymatic biodegradability of these modified amylopectins, 
because of the specificity of the enzymatic degradation system.  
The first aim of this thesis was to establish a method to modify starch with relatively large 
molecule PEI (0.8 kDa), while maintaining the structure and characteristics of the starch as 
much as possible. Once the optimal conjugation method was found, two parameters, MW of 
the starch and the modification amount of PEI, were varied in the synthesis reaction. The 
resulting starch-PEI conjugated polymers were analyzed to verify the altered parameters and 
used as candidate polymers for gene delivery vector. 
 
 
 
Scheme 1: Total synthesis of the starch-graft-PEI polymers 
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3.2 Experimental Methods 
3.2.1 Materials 
Partially hydrolyzed potato starch (MW was around 1,300,000 g/mol, amylose content was 
around 33%) was a kind gift from AVEBE (Veendam, NL). Two different molecular weight 
(MW) branched polyethylenimine, (b-PEI, 25 kDa) (s-PEI, 0.8 kDa) were purchased from 
Sigma-Aldrich Co. (St. Louis, MO) and used without further purification. 2,2,6,6-
Tetramethyl-1-piperridinyloxy (TEMPO), Sodium hypochlorite solution (12%), 2-Chloro-4,6-
dimethoxy-1,3,5-triazine (CDMT) and 4-Methylmorpholine (NMM) were purchased from 
Sigma-Aldrich. Sodium borohydride was purchased from Merck. Purified water was produced 
by Milli-Q water purification system (Merk Millipore, Billerica, U.S.A.).  
 
3.2.2 Oxidation of the starch 
The water soluble oxidized starches were synthesized by TEMPO-mediated system
110
 
(Scheme 2). Briefly, 10 g of dried starch was suspended in 400 ml of purified water and 
heated at 95 °C for one hour. The suspension was cooled down to room temperature (R.T.) 
and TEMPO (4 mg/g starch) was added. The appropriate amount of sodium hypochlorite 
solution was added slowly over 2 h. During the addition of the sodium hypochlorite solution, 
pH of the reaction mixture was controlled to 8.5 by adding 1 M sodium hydroxide. After the 
addition of the sodium hypochlorite, sodium borohydride was slowly added (Scheme 3). The 
resulting solution was stirred overnight and then purified by ultrafiltration (Vivaflow200: 5 
kDa Hydrosart membrane, Sartorius Stedim Biotech GmbH, Goettingen, Germany). Purified 
water was used for washing. The product was dried by lyophilization (Alpha 2-4, Martin 
Christ GmbH, Osterode, Germany). 
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Scheme 2: Mechanism of TEMPO-mediated oxidation 
 
 
 
 
Scheme 3: Starch oxidation 
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3.2.3 Fractionation and characterization of the oxidized starch 
Oxidized starch was further separated into three fractions depending on its MW using an 
Ultrafiltration system with purified water (Vivaflow200: 30 kDa Hydrosart membrane, 100 
kDa Polyethersulfone membrane, Sartorius Stedim Biotech GmbH, Goetingen, Germany). 
Every fraction was collected, lyophilized and characterized by gel permeation chromatography 
(GPC, HLC-8320GPC, Tosoh, Japan), equipped with online viscometer (ETA-2010, PSS, 
Germany), on SUPREMA 1000 and 30 columns (PSS, Germany) at a flow rate 1 mL/min at 
35 °C in 1 M Sodium nitrate. Pullulan standards were used for the universal calibration. The 
degree of substitution by sodium carboxylate (DSCOONa) was determined by a colorimetric 
assay according to Blumenkrantz et al.
111
. A Calibration curve was made using glucuronic acid 
(Figure 10) and used to calculate the DSCOONa of the each oxidized starch. 
 
(a) 
 
(b) 
 
Figure 10: Calibration of the Blumenkrantz Assay, modified from ref.
112
 
(a) Blumenkrantz solution containing different amount (µg) of glucuronic acid 
(b) Calibration curve and its coefficient of determination (R2) 
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3.2.4 Synthesis of 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4methyl-morpholinium Chloride 
(DMTMM) 
The synthesis of DMTMM was done according to Kunishima et al.
113
 (Scheme 4). Briefly, 
NMM (5.05 g, 50 mmol) was added to a solution of CDMT (9.65 g, 55 mmol) in THF (150 
mL) at room temperature. A white solid appeared within several minutes. The solution was 
further stirred for 30 min and the white precipitation was collected by filtration. The product 
was washed with THF three times and dried under vacuum at 25 °C for 36 h. 
The characterization of the DMTMM was done by 
1
H-NMR. Bruker NMR Magnet System 
400 MHz Ultra shield plus: in D2O, δH DMTMM: 4.56 ppm (m, 2H), 4.09 ppm (m, 2H), 3.89 
(m, 4H, N- CH2-CH2-O), 4.20 ppm (s, 6H, O- CH3,), 3.56 ppm (s, 3H, N+-CH3).  
 
 
 
 
Scheme 4: Synthesis of DMTMM 
 
 
3.2.5 Conjugation of oxidized starch and PEI (Starch-graft-PEI) (Scheme 5) 
The reaction between sodium carboxylate groups of starch and amine groups of s-PEI was 
done according to Kunishima et al.
113
. Briefly, starch (500 mg, 0.57 mmol sodium 
carboxylate) was solubilized in 50 mL of solvent mixture (1 : 4 = purified water : DMSO) in a 
round-bottomed flask followed by the addition of 0.68 mmol conjugation reagent, 4-(4,6-
Dimethoxy-1,3,5-triazin-2-yl)-4methyl-morpholinium Chloride (DMTMM), while stirring. 
The reaction mixture was stirred for 30 min. in R.T. to activate the sodium carboxylate groups. 
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Subsequently, 17 mmol of s-PEI in 100 mL of solvent mixture (1 : 4 = purified water : 
DMSO) was slowly added. The reaction was proceeded with stirring for 72 h at R.T. and 
extensively dialyzed (3.5 kDa Mw cut-off, regenerated cellulose membrane, Fisher scientific) 
against purified water. The water insoluble white precipitation was removed by filtration and 
the reaction solution was collected and lyophilized. The complete purification (no-existence of 
unreacted s-PEI) was confirmed by GPC measurement. The amount of s-PEI modification 
(wt%) was determined by 
1
H-NMR. Bruker NMR Magnet System 400 MHz Ultra shield plus: 
in D2O, δH Starch: (1H, 5.12 – 5.58 ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), PEI: 
(NH2-CH2-CH2, 2.20 – 3.45 ppm). The purity of starch-g-PEI was examined by GPC 
measurement (HLC-8320GPC, Tosoh, Japan) on SUPREMA-MAX 1000 and 30 columns 
(PSS, Germany) at a flow rate 1 mL/min at 35 °C in 1 % formic arid. 
 
 
 
Scheme 5: Conjugation reaction between starch and PEI 800 Da 
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3.3 Results and discussion 
3.3.1 Oxidation of the starch 
The oxidized water-soluble starch formed the precursor of the starch modification with s-
PEI.The selective C6 position of COONa groups produced in this reaction, was later 
conjugated with amine groups of s-PEI (Scheme 1). Just after the oxidation procedure, the 
starch was polydisperse in nature and showed very broad peak in the gel permeation 
chromatography (GPC) measurement (Polydispersity: PD = 5 - 6). The oxidized starch was 
therefore separated into three different fractions, on the basis of MW, as this was one of the 
parameters selected for optimization in order to tailor the characteristics of the final product. 
The three fractions each showed a narrower PD than non-separated starch, proving that the 
separation worked successfully (Figure 11). Following starch oxidation and fraction 
separation, the degree of substitution (DSCOONa) was determined by the Blumenkrantz Assay
111
. 
The DS could be well controlled to the desired value via changing the amount of sodium 
hypochlorite used for the reaction. Three different DSCOONa were produced, of approximately 
10 %, 20 % and 40 %. The MW, PD and DSCOONa of oxidized water-soluble starches before 
and after separation into three fractions are summarized in Table 3. 
 
 
Figure 11: GPC spectra of oxidized starch and three different MW fractions 
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Table 3: Characteristics of oxidized starch and different MW fractions 
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3.3.2 Synthesis and characterization of the DMTMM 
DMTMM is insoluble in THF while both CDMT and DMTM are soluble. This makes 
isolation of DMTMM simple when it is prepared in THF. The characterization of the 
DMTMM was done by 
1
H-NMR in D2O, δH DMTMM: 4.56 ppm (m, 2H), 4.09 ppm (m, 2H), 
3.89 (m, 4H, N- CH2-CH2-O), 4.20 ppm (s, 6H, O- CH3,), 3.56 ppm (s, 3H, N+-CH3). The 
1
H-
NMR spectrum of Figure 12 showed the successful synthesis and purification of the DMTMM. 
Additional, the data of the elemental analysis also showed the successful synthesis of the 
DMTMM. Anal. Calcd. (%) for C10H17ClN4O3: C, 43.40; H, 6.19; N, 20.25. Found: C, 43.97; 
H, 5.95; N, 20.20. 
 
 
Figure 12: 
1
H-NMR spectrum of the synthesized DMTMM 
in D2O, δH DMTMM: 4.56 ppm (m, 2H), 4.09 ppm (m, 2H), 3.89 (m, 4H, N- CH2-
CH2-O), 4.20 ppm (s, 6H, O- CH3,), 3.56 ppm (s, 3H, N+-CH3).  
 
 
3.3.3 Conjugation of oxidized starch and PEI (Starch-graft-PEI) 
Modification of starch has generally been performed with small molecules such as acetic 
anhydride, in order to form acetylated starch
114
; ethylene oxide, to produce hydroxyethyl 
starch
115
; or, more recently, with a carbonyldiimidazole activation system, resulting in cationic 
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starch
109
. Modification with larger or more complex molecules is not an easy task because of 
the steric inaccessibility of the molecules to the reaction site of the starch. Therefore certain 
linkers
116,82
 are often used as an intermediate product to introduce such molecules, in a process 
which needs at least two reaction steps. Cui et al.
82
 used a biocleavable acetal linker to modify 
dextran with amine functionalized molecules and synthesized a smart gene delivery vector. 
Dialdehyde starch
108,117
 is also often used as an intermediate product and has been reported to 
result in a successful modification. However, the drawback of using dialdehyde starch as an 
intermediate material is that the glucose ring would be opened and the key characteristic of the 
starch (e.g. enzymatic biodegradability) as a result would be lost. Since we aimed to 
synthesize an enzymatically-degradable starch-based polymer and to keep the original 
structure of the starch as much as possible, using dialdehyde starch was not the best option. 
Consequently, we aimed to conjugate the C6 position of COONa groups (which, as mentioned 
above, were made in the starch oxidation process) directly with amino groups of the s-PEI. 
The conjugation reaction between carboxylic acid groups of starch (ion exchanged from 
COONa) and amine groups of s-PEI was first tried using the DCC/HOBt and EDC/NHS 
conjugation reagent. However, despite many trials of this reaction and altering reaction 
conditions such as used solvent, temperature and time, an effective reaction was not achieved. 
A successful conjugation product was however obtained using DMTMM as a reaction reagent 
in accordance with Kunishima et al.
113
. DMTMM is a water-soluble reaction reagent, which is 
easy to handle and is also suitable for carboxylate conjugation. It was synthesized by the 
reaction of CDMT and NMM (Scheme 4). The optimal reaction conditions for conjugation 
were found to be the use of 1.2 times excess of DMTMM against COONa groups, in the 
mixed solvent of water: DMSO = 1 : 4, at room temperature for 72 hours. 
The reaction is thought to be initiated by addition of a carboxylate anion of starch to DMTMM 
to give an activated ester, which undergoes attack by an amine of s-PEI to give the amide 
bond (Scheme 6). The strength of this DMTMM conjugation reaction is; a) stronger activation 
system of carboxylate groups that is needed for the successful conjugation, b) DMTMM is 
easily removable after the reaction by washing with water, and c) through the mild reaction 
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condition at R.T. the side reaction possibly occurred in higher temperature (e.g. degradation of 
the starch that is occurred in case of DCC/HOBt at 50 °C for 72 h) can be avoided. 
 
 
Scheme 6: Mechanism of conjugation reaction using DMTMM reaction reagent 
 
 
3.3.4 Characterization of the synthesized Starch-graft-PEI polymers 
The amount of s-PEI bound on the starch backbone and the total MW were calculated from 
the results of 
1
H-NMR, based on the integration ratio of 1H of starch (5.1 – 5.6 ppm) and s-
PEI protons (2.20 – 3.45 ppm). The higher the degree of modification with s-PEI, the higher  
was the observed s-PEI-derived proton peak at 2.2 – 3.45 ppm (Figure 13). Approximately 20, 
30 or 35 wt% of s-PEI was introduced, depending on the DSCOONa of the starch backbone. In 
35 wt%, every 9th glucose carries a s-PEI side chain, while in 20 wt% only every 19th glucose 
ring is modified.  
The higher degree of modification with s-PEI was the more difficult to perform, because of 
the steric hindrance. Formation of a water-insoluble white precipitate was observed more 
frequently in the reaction involving the larger MW starch backbone with higher DSCOONa. This 
byproduct was therefore likely to be large MW conjugates of starch and s-PEI that became 
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insoluble in water, and as such, these were removed by centrifugation. As a result, the final 
yield of 30 wt% modified starch-g-PEI was 40 to 60 %. 
 
 
 
Figure 13: 
1
H-NMR spectra of synthesized starch-g-PEI polymers 
in D2O, δH Starch: (1H, 5.12 – 5.58 ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), 
PEI: (NH2-CH2-CH2, 2.20 – 3.45 ppm). 
 
 
In the FT-IR measurement, no absorbance of COONa (1604 cm
-1
) was observed in the starch-
g-PEI, confirming that all the COONa groups had been converted (Figure 14). However, the 
amount of s-PEI calculated from the results of 
1
H-NMR was lower than the expected value. 
This difference allows for estimation of the cross-linking of starch and s-PEI, possible as both 
species have several reactive sites of sodium carboxylate and amino groups, respectively. 
Calculated from the 
1
H-NMR results, one s-PEI molecule reacted with 1.7 - 3.2 COONa 
groups on the starch backbone. 
In the following, polymers are named with a systematic name, according to their DSCOONa (S1 
= 10%; S2 = 20% and S3 = 40%) and the MW of starch backbone. The subscript letter S 
stands for small MW=30-50 kDa; M for medium = 100-120 kDa; L for large = 500-800 kDa. 
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The polymer without the subscript letter indicate the non-fractionated starch (MW=30-800 
kDa). The subscript letter PEI stands for the modification amount (wt%) with s-PEI. 
 
 
 
Figure 14: IR spectra of the starch: before and after the PEI modification 
 
 
In the GPC measurement of starch-g-PEI polymers (Figure 15), the product peaks were 
observed to be mono-modal and PD values were low. These monomodal peaks and low PD 
values showed that the cross-linking was not intermolecular, but rather intramolecular. 
Intermolecular cross-linking might have also occurred, but it is reasonable to consider that the 
product of such intermolecular cross-linking would have an extremely large molecular weight; 
as such it was likely removed during the modification/purification process as part of the 
previously mentioned water-insoluble white precipitate.  
Another important point of the GPC profile is that the product peaks were shifted in the 
direction of larger MW as compared to the pure s-PEI, which implies a successful conjugation 
reaction. Additionally, no peaks corresponding to the free s-PEI was observed in the 
conjugated products, which proves the successful purification and removal of excess s-PEI 
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from the reaction mixture. It can also be seen that each product has a different MW, depending 
on the MW of the starch backbone which was used. Therefore, the MW of the products can be 
controlled by changing the MW of the starch backbone. 
 
 
 
Figure 15: GPC spectra of the starch-graft-PEIs with different MW starch backbones 
and s-PEI 
 
 
Summarizing the results of polymer synthesis, starch-g-PEIs were successfully synthesized by 
the precise control of two parameters: MW of the starch backbone and modification amount 
with s-PEI. The detailed characteristics of synthesized polymers are summarized in Table 4. 
 
 
 
Synthesis of the Starch-graft-PEI polymers   
44 
Table 4: Characteristics of the synthesized Starch-g-PEI polymers 
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3.4 Conclusion 
For the gene delivery application, as a non-viral gene delivery carrier, we have successfully 
synthesized cationic polymer composed from potato starch and s-PEI. The conjugation 
reaction of the starch and s-PEI was tested using different conjugation reagents, DCC/HOBt, 
EDC/NHS and DMTMM. Through the DCC/HOBt and EDC/NHS showed no conjugated 
product, DMTMM provided the conjugated product. The successful reaction was observed 
using the DMTMM reaction reagent. The optimal reaction conditions for conjugation were 
found to be the use of 1.2 times excess of DMTMM against COONa groups, in the mixed 
solvent of water: DMSO = 1 : 4, at room temperature for 72 hours. The optimized reaction 
condition was milder than the reaction condition of DCC/HOBt or EDC/NHS, and did not 
cause degradation of the starch backbone. Additionally the removal of the DMTMM after the 
reaction was easily possible by washing with water. By using DMTMM reaction reagent, we 
were successful in the introduction of effective and easy to handle reaction conditions. 
Two parameters, the MW of the starch backbone and the modification amount of s-PEI, were 
closely controlled and a series of starch-g-PEIs with different characteristics was successfully 
obtained (Figure 16). The synthesized starch based cationic polymers with different 
characteristics are worth to study their ability as a non-viral gene delivery vector. A systematic 
study of all the polymers shown in Figure 16 as gene delivery carriers, could help to 
understand the impact of MW and amount of cationic charge on transfection efficacy and 
safety.  
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Figure 16: Scheme depicting the synthesized Starch-g-PEI polymer series 
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4.1 Introduction 
The implementation of gene delivery in a clinical setting is an area of significant interest. This is 
due on the one hand to its many prospective applications. A large number of human diseases such 
as cancer, cardiac disorders and neurodegenerative diseases are attributable to a distinct genetic 
defect. Prophylactic (e.g. vaccination
118
) or therapeutic strategies which do not rely on complete 
transfection of target cells could also profit from transgene expression
119
. On the other hand, 
nucleic acid-based actives are becoming more and more advanced. The last decade brought 
programs for nucleotide sequence optimization, base modifications for improved stability and the 
use of mRNA for faster translation. As a result of such advances, the same delivery efficacy is 
now capable of producing a higher therapeutic effect. For gene delivery technologies this reduces 
the need for complete transfection. However, the safety of any such technology remains of utmost 
importance. As a consequence, recent research pays more attention to the safety and 
biodegradability of the transfection agents.  
This chapter reports the study of the starch-g-PEI polymers synthesized in chapter 3 (Figure 16)  
as gene delivery vectors, focusing on their ability to show high transfection efficiency and safety. 
This study was driven by the hypothesis (Figure 17) that it should be possible to synthesize a safer 
(less cytotoxic and biodegradable) polymer which retains transfection efficiency by grafting of s-
PEI to a suitable biopolymer. 
Thus, our approach was to use water-soluble starch, oxidize it as a first step for more controlled 
conjugation, and subsequently modify it with just enough s-PEI (Scheme 1) to achieve a 
comparable transfection efficacy to b-PEI. The transfection-effective starch-g-PEI polymers were 
then tested for cytotoxicity and enzymatic degradability. By testing the starch-g-PEI polymer 
series with different MW of the starch and modification amount of s-PEI, we were able to identify 
some characteristics that the cationic polymer should possess as a superior gene delivery vector. 
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Figure 17: Scheme of the working hypothesis of replacing PEI partially to non-toxic 
starch backbone 
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4.2 Experimental Methods 
4.2.1 Materials 
A plasmid DNA (pDNA) encoding the modified firefly luciferase was bought from Promega 
(pGL3-basic vector), and another pDNA encoding the fluorescent protein AmCyan was 
bought from Clontech (pAmCyan1-C1). Plasmids were propagated in E. coli DH5α competent 
cells (Invitrogen), isolated and purified using Qiagen endotoxin-free plasmid Maxi kits 
(Qiagen) as per manufacturer’s protocol. The quantity and quality of purified pDNA were 
evaluated by spectrophotometric analysis at 260 and 280 nm. Purified pDNA was suspended 
in purified water and stored at -20 °C until use. A transfection reagent, jetPRIME
TM
 was 
purchased from Polyplus transfection (Illkirch, France). A549 cells No ACC 107 were 
purchased from DSMZ GmbH (Braunschweig, Germany). Cell culture medium (RPMI 1640) 
was purchased from PAA Laboratories GmbH (Pasching, Austria) and fetal bovine serum 
(FBS) was purchased from Lonza (Basel, Switzerland). The Luciferase assay kit was 
purchased from Promega (WI, U.S.A.). The BCA Protein Assay Reagent Kit was purchased 
from Sigma-Aldrich. 
 
4.2.2 Polyplex formation 
The stem polymer solutions were made by solubilizing the polymers in purified water in the 
concentration of 1 mg/mL and stored at -20 °C until use. The stem aqueous solution of each 
polymer and pDNA were further diluted with purified water to the suitable concentration and 
incubated for 10 min at 50 °C. An appropriate amount of pDNA (N/P = 10, 12, 14 and 16: 
ratio between nitrogen of polymer and phosphate of pDNA) was added to polymer solution. 
The amount of N was calculated based on the weight of s-PEI side chain. If the X g of s-PEI 
side chain is contained in starch-g-PEI, the mol of N atom was calculated by X / 43. Here, 43 
is the molecular weight of the PEI repeating units, -CH2CH2NH-. After the addition of pDNA, 
solution was immediately mixed for 10 seconds by vortex and incubated for 30 min at R.T. 
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4.2.3 Polyplex characterization 
The characterization (size, particle homogeneity and zeta potential) of polyplexes was studied 
by Zetasizer Nano-ZS (Malvern Instruments, Worcestershire, UK) equipped with a 4 mW He–
Ne laser employing a wavelength of 633 nm and a backscattering angle of 173° at 25 °C.  
Polyplexes were analyzed as produced, without further dilution. The reported size is the z-
average diameter (intensity based) of 3 measurements. 
 
4.2.4 Transfection experiments 
Transfection efficiency was evaluated with A549 cells. A549 cells were maintained in RPMI 
cell culture medium supplemented with 10 % (v/v) FBS at 37 °C in 5 % CO2. 
 
4.2.4.1 Luciferase transfection assay 
A549 cells were seeded in a 24-well plate at a density of 25,000 cells per well in 500 µL of the 
cell culture medium. Polyplexes with luciferase pDNA (pGL3) in Hank's Balanced Salt 
Solution (HBSS buffer pH 7.4, 500 µL/ well) were added on the cells. In all the experiments 
the amount of pDNA was kept constant at 1 µg pDNA/well.). After 4h of incubation the 
polyplex solution was replaced by cell culture medium and the cells were further incubated for 
48 h. Luciferase gene expression was evaluated using a Luciferase assay kit from Promega 
and the relative light units (RLU) were measured by Tecan microplate reader (Tecan 
Deutschland GmbH, Crailsheim, Germany).  Protein quantification was performed with BCA 
assay kit at 570 nm. The transgene expression was normalized for the protein content. All 
experiments were conducted in duplicate. 
 
4.2.4.2 Flow cytometry 
The amount of transfected cells was determined by flow cytometry. A549 cells were seeded in 
a 12-well plate at a density of 50,000 cells per well in 1 mL of the cell culture medium. 
Polyplexes with pDNA encoding the fluorescent protein AmCyan in HBSS buffer pH 7.4 were 
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added on the cells (2 µg pDNA in 1 mL HBSS buffer pH 7.4 / well), and incubated 4 h. After 
the transfection, the polyplex solution was replaced by cell culture medium and followed by 
further 48 h of incubation. The cells were washed three times with PBS, collected and 
centrifuged at 1,400 rpm for 4 min. The resulting cell pellet was suspended in 500 μL of cell 
culture medium and analyzed by flow cytometry, with excitation by argon laser at 488 nm and 
emission through the 515 – 545 nm filter. 10,000 cells per sample were analyzed using BD 
FACSCalibur
TM
 (Becton-Dickinson, Heidelberg, Germany). The percentage of cell-associated 
ﬂuorescence was determined using the computer program FlowJo (version 7.2.5, Tree Star, 
Stanford, CA). All experiments were conducted in duplicate. 
 
4.2.4.3 CLSM observation 
The images of the transfected A549 cells were taken using CLSM. A549 cells were seeded in 
a 24-well plate at a density of 25,000 cells per well in 500 µL of the cell culture medium. 
Polyplexes with pDNA encoding the fluorescent protein AmCyan in HBSS buffer pH 7.4 were 
added on the cells (1 µg pDNA in 1 mL HBSS buffer pH 7.4 / well), and incubated 4 h. 
Following the incubation, the polyplex solution was replaced by cell culture medium and 
incubated for further 48 h. The cells were washed with PBS, incubated for 10 min at 37 °C 
with rhodamine ricinus communis agglutinin solution ( 0.625 µg in 500 µL PBS buffer / well) 
for a red fluorescent staining of the cell membrane (emission: 550nm, excitation: 575nm).  
Then the cells were washed three times with PBS buffer and fixed by 4 wt% 
paraformaldehyde (in PBS buffer, for 10 min at R.T.). The cells were further washed three 
times with PBS and the cell nuclei were stained with DAPI (emission: 461 nm, excitation: 374 
nm) by the incubation for 5 min. at R.T. Finally the cells were washed twice with PBS buffer 
and investigated by CLSM (LSM 510 META, Carl Zeiss, Oberkochen, Germany), equipped 
with an argon/neon laser and a 63× water immersion objective. Images were captured using 
DAPI channel (excitation 360 nm, band pass filter 390–465 nm), rhodamine channel 
(excitation 488 nm, band pass filter 500–530 nm), and AmCyan channel (excitation 543 nm, 
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band pass filter 560–615 nm). The measurements and image analysis were performed using 
the Zeiss LSM 510 software. 
 
4.2.5 Cytotoxicity studies 
LDH and MTT assay were performed to study the in vitro cytotoxicity of the starch-g-PEI 
polymers and their complexes. The cytotoxicity of starch-g-PEI polymers after a 3h 
incubation with α-amylase was also investigated. The A549 cells were seeded in a 96-well 
plate at a density of 10,000 cells per well in 200 µL of the cell culture medium. Once 
confluent, polymers or their polyplexes in HBSS buffer pH 7.4 were applied on the cells and 
incubated for 4 h at 37 °C with gently shaking. As reference, HBSS buffer (negative, 0%) and 
0.1% (w/w) Triton X-100 solution (ICN, Eschwege, Germany) (positive, 100%) in HBSS 
buffer were applied. To ensure the no interference of polyplexes to the test system, polyplexes 
without any cells were also tested. The cytotoxicity calculation and determination of LD50 
values were performed using Sigmaplot Version 12.0.  
 
4.2.5.1 LDH assay 
After 4 h incubation of the above-mentioned 96-well plate, the 100 µL of incubated HBSS 
solution was transferred to another 96-well plate. The 100 µL of LDH test solution (Roche 
Cytotoxicity LDH kit) was added to each well and the plate was incubated in dark for 5 min at 
R.T. The absorbance at 492 nm was read by Tecan microplate reader.  
 
4.2.5.2 MTT assay 
After the 4 h incubation of the above-mentioned 96-well plate, the test solution was removed 
and cells were washed once with HBSS buffer. The fresh HBSS buffer with 10 % (vol.) of 
MTT reagent (5 mg/mL) was added, and incubated further 4 h at 37 °C with gently shaking. 
The solution was removed and cells were dissolved in DMSO and incubated 10 min at 37 °C 
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with gently shaking and protected from light. The absorbance at 550 nm was read by Tecan 
microplate reader.  
 
4.2.6 Biodegradability study by α-amylase 
Biodegradability study of starch-g-PEI was performed according to Xiao et al.
120
. Briefly, 40 
µL of polymer solution (2 mg/mL in purified water) was added into 96-well plate. Then, 40 
µL of α-amylase solution (1288 µunit/mL in 0.1 M phosphate buffer pH 7) was added to each 
well. The plate was then incubated for 15, 30, 45, 60, 75 and 90 min at 37 °C and the digestion 
was stopped by adding 25 µL of 1 M hydrochloric acid. Subsequently, 100 µL of iodide color 
reagent was added and the absorbance at 580 nm was read by Tecan microplate reader. 
Calibration curves were made concurrently with experiments for each sample. As a 
comparative study, water soluble starch without any modification (Merck, Product number: 
101253) was also tested. All the experiments were conducted in triplicate. The remaining 
starch amount in the each sample was calculated using the calibration curve and plotted 
against the incubation time with α-amylase. The degradation rates (nmol/min) and R2 values 
were calculated from the linear regressions. 
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4.3 Results and discussion 
4.3.1 Polyplex formation 
A polyplex is an electrostatic complex of negatively charged nucleotides (here pDNA) and 
positively charged polymers. Using the synthesized starch-g-PEIs with different characteristics, 
polyplexes were formed with pDNA. A polyplex with b-PEI (25 kDa) was also produced as a 
control, in accordance with Boussif et al
44
. (Nitrogen atom / Phosphate atom = N/P = 10). The 
size and zeta potential of polyplexes were measured using a Zetasizer (Malvern Instruments, 
Worcestershire, UK) (Table 5). In general terms, the polyplexes formed from the starch-g-PEI 
with a low amount of s-PEI modification (S1 series, 20 wt%) were bigger than the others and 
not uniform in their size distribution, as indicated by a high Polydispersity index (PDI) value. 
A possible explanation for this could be that s-PEI side chains were non-homogenously and 
insufficiently distributed in such a structure, preventing the formation of stable polyplexes. 
Starting from 30 wt% modification, all polymers were able to form polyplexes with relatively 
uniform size distributions and with mean sizes of 70 - 100 nm. It has been shown that the size 
of polyplexes plays a very important role for cellular uptake mechanisms in many cell lines. 
Mintzer et al.
121
 stated in their review article that the optimal size of polyplexes based on 
cationic polymer-DNA is between 70 to 90 nm. The polyplexes from S2 and S3 series mostly 
fit in this size range, and were therefore expected to show good cellular uptake. 
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Table 5: Characteristics of the generated polyplexes (N/P = 14) with starch-g-PEI 
polymers 
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4.3.2 Transfection experiments 
The transfection efficiency of the polyplexes from synthesized polymers was studied in A549 
cells. This AT-II cancer cell line is obtained from the alveolar region of the human lung and 
widely used for in vitro transfection experiments. 
 
4.3.2.1 Luciferase transfection assay 
A luciferase assay was used for the screening of transfection efficiency because of the high 
throughput and sensitivity of this assay. First, the transfection efficiencies using all the 
polymers were compared with that of b-PEI (Figure 18(a)). N/P = 10 was used for all polyplex 
formulations according to Boussif et al.
44
. As is evident from Figure 18(a) there is a clear 
difference in transfection between the different s-PEI modification amounts. The 30 wt% s-
PEI modified samples showed the best transfection efficiency. This result indicates that a 
modification of more than 30 wt% would not help to increase the transfection efficiency 
further. A possible explanation for this would be that the higher density of cationic charges in 
35 wt% s-PEI modified polymer can interact very strongly with pDNA and fail to release it 
efficiently in the cells. In Figure 18(b), the N/P ratio was optimized for the best transfection 
efficiency using the 30 wt% modified samples. Polymers with N/P = 14 showed the best 
transfection, and S2L-g-PEI30 showed an even better transfection efficiency than b-PEI. The 
MW of the starch backbone can also be seen to play an important role. The larger the MW of 
the bakcbone, the higher transfection was observed. This result fits with the findings of Bishop 
et al.
122
, who studied the influence of MW of poly(β-amino ester)s on transfection efficiency. 
Based on the results presented in Figure 18, the 30 wt% s-PEI modified polymers, S2L-g-PEI30, 
S2M-g-PEI30 and S2L-g-PEI30, were chosen as the three best candidates for gene delivery 
vectors and were further studied. 
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Figure 18: Results of the luciferase transfection assay.  
     (a) comparison of various wt% PEI modification amount against the b-PEI 
          control; all at N/P = 10 ratio; 
     (b) optimization of N/P ratio with the 30 wt% series of starch-graft-PEI; 
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4.3.2.2 Flow cytometry 
The amount of transfected cells was determined by flow cytometry (Figure 19). Compared 
with b-PEI (10.4 %), two starch-g-PEIs, S2M-g-PEI30 (16.0 %) and S2L-g-PEI30 (20.1 %), 
showed a superior number of transfected cells. The best tested sample, S2L-g-PEI30 (20.1 %), 
showed almost double the percentage of transfected cells of b-PEI (10.4 %) and even gave a 
comparable result to that of a commercially-available positive control, jetPRIME
TM
 (22.8 %). 
When comparing the three tested samples, the larger starch backbone showed the higher 
transfection efficiency (S2-g-PEI30 6.0 %, S2M-g-PEI30 16.0 % and S2L-g-PEI30 20.1 %). This 
was the same tendency as observed in the luciferase transfection experiment, and verified that 
the MW of the starch backbone has an impact on the transfection efficiency. It can therefore 
be concluded that a starch backbone MW of approx. 100,000 g/mol is necessary for successful 
transfection. 
 
 
 
Figure 19: Results of the flow cytometry analysis of A549 cell transfection 
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4.3.2.3 CLSM observation 
CLSM pictures were additionally taken for the optical confirmation of cellular transfection 
(Figure 20). The green fluorescence from successfully expressed pAmCyan proteins was 
observed in response to incubation of cells with the starch-g-PEI samples, as well as the 
positive controls, jetPRIME
TM
 and b-PEI. 
 
 
 
Figure 20: Confocal microscopy images of A549 cells transfected with pAmCyan 
using S2M-g-PEI30, S2L-g-PEI30 and S2-g-PEI30 polymers.  
green = AmCyan protein, red = RCA stained membrane, blue = DAPI stained nuclei. 
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4.3.3 Cytoxicity 
The cytotoxicity of the three best polymer candidates and their polyplexes was studied with 
MTT and LDH colorimetric assays. The MTT assay measure the metabolic activity of living 
cells  by the formation of blue formazan crystals. The LDH assay, on the other hand, can 
determine cellular damage by measuring the amount of lactate dehydrogenase (LDH) released 
from cells that have a loss of membrane integrity.  
In Figure 21 (a), the results of the MTT study of S2L-g-PEI30 as a representative sample are 
shown. The gray area indicates the concentration needed for optimal transfection. In the case 
of all three polymers and their polyplexes, cell viability was more than 84 % at the 
concentration of successful transfection. From Figure 21 (a), it can be seen that the 
synthesized S2L-g-PEI30 and its polyplex showed levels of cytotoxicity which were lower than 
PEI 25 kDa. The polyplex from S2L-g-PEI30 showed less cytotoxicity than the pure polymer. 
This may be due to the decrease in cationic net charge in the polyplex as a result of the partial 
neutralization by polyplex formation with negatively charged pDNA. Furthermore, the most 
interesting observation is the greatly reduced cytotoxicity of S2L-g-PEI30 after the 3 h 
incubation with α-amylase, which indicates degradation of the S2L-g-PEI30. It is supposed that, 
with the decreasing MW of the S2L-g-PEI30 as a result of degradation, the multivalency of the 
polymer is also reduced. Correspondingly, the cytotoxicity greatly improves. 
In Figure 21 (b), the calculated LD50 values of the three best starch-g-PEIs and b-PEI from 
the MTT and LDH study are summarized. The (A) values were calculated based on the exact 
weight of the polymer itself. Compared with the LD50 value of b-PEI, the starch-g-PEIs show 
a 3 - 6 fold lower level of cytotoxicity. Although, the (B) LD50 values, calculated based on the 
weight of the PEI part of polymers, should also be noted. As the synthesized polymers contain 
starch as well as s-PEI, (A) LD50 was normalized based on the s-PEI weight of the polymer to 
(B) LD50. Since the synthesized polymers have less cationic charges than b-PEI of the same 
weight, greater amounts (weights) of these polymers are required to get the best transfection 
efficiency. The polyplexes from starch-g-PEIs and b-PEI contain almost the same amount of 
PEI, and in that case there is almost no advantage in the cytotoxicity represented in (B) LD50. 
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The starch-g-PEIs only show an advantage with respect to cytotoxicity following the 
degradation of the starch backbone. Such degradation would result in small MW fragments of 
the glucose units and s-PEI; these are therefore the entities implied in the result of “S2L-g-
PEI30 after 3h incubation with α-amylase” in Figure 21 (a). A further biodegradability study of 
the synthesized polymers has been done in the following experiments.  
 
 
 
Figure 21: Results of the cytotoxicity tests (A549 cells) 
(a) Results of MTT test with different transfection reagents (gray area shows the 
concentration needed for the best transfection efficiency). The cytotoxicity of S2L-g-
PEI30 is decreased after enzymatic degradation. (b) LD50s of S2 polymers and b-PEI 
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4.3.4 Biodegradability study by α-amylase 
The biodegradability of the three best polymer candidates was studied by α-amylase using an 
iodine-based method
120
. As a comparison, water-soluble starch without any modification was 
also tested. It is known that α-amylase is less effective in degrading modified starches because 
of its molecular specificity. It was therefore of interest to test the degradability of our 
synthesized polymers, to determine whether they could still be degraded by the enzyme even 
after modification with s-PEI. In Figure 22 (a), the incubation time with α-amylase vs. the 
amount of remaining starch in nmol can be seen. Linear regression analysis of these profiles 
resulted in coefficient of determination (R
2
) values close to 1 in all cases (Figure 22 (b)), 
confirming that the amount of starch in all samples declined in a linear manner over the 90 
min experimental period.  Thus, it is assumed that the enzyme was fully saturated and that 
degradation followed zero order kinetics. The calculated rates of the degradation of starch-g-
PEIs were 1.7 – 2.2 times slower than that of unmodified starch, which is regarded as 
reasonable considering their modification with s-PEI side chains. Nevertheless, synthesized 
starch-g-PEIs do appear to be degraded by α-amylase, despite the fact that their degradation 
rate was slower than that of non-modified starch. This biodegradability of the synthesized 
polymers is a big advantage in terms of reducing cytotoxicity, as we have already observed in 
the MTT and LDH tests, since the starting materials of starch and s-PEI are virtually non-toxic. 
This benefit is expected to also be seen following repeated administration in vivo studies in 
the near future, since starch-g-PEIs can be degraded and excreted from the body. 
  
Evaluation of the Starch-graft-PEI polymers as gene delivery vector   
64 
 
Figure 22: Biodegradability by α-Amylase over 90 min,  at 37 °C 
(a) incubation time with α-amylase vs. the amount of remaining starch in nmol 
(b) rate and coefficient of determination of the starch-g-PEI degradation 
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4.4 Conclusion 
 
The starch-g-PEIs, synthesized in Capter 3, could form nano-sized polyplexes with pDNA, 
some of which showed a very promising transfection efficiency in the A549 cell line. The 
successful transfection was observed both qualitatively and quantitatively, by luciferase assay 
and by flow cytometry and CLSM analysis of fluorescent protein-expressing cells. The 
transfection efficiency was shown to depend not only on the modified amount of s-PEI, but 
also on the MW of the starch backbone. The optimal combination was approximately 30 wt% 
of s-PEI modification onto a >100kDa MW starch backbone. The produced starch-graft-PEI 
polymers providing this combination, showed even higher transfection efficiency than b-PEI. 
Furthermore, we demonstrated a lower cytotoxicity of the synthesized starch-g-PEI polymers 
than b-PEI. After the incubation process with α-amylase, the cytotoxicity of the starch-g-PEI 
polymer was dramatically decreased. It implied the starch-g-PEI polymer was degraded and 
became much less toxic small fragments. Additionally, the iodine-starch colorimetric assay 
proofed the biodegradability of the starch-g-PEI polymers by α-amylase more precisely.  
In essence, our hypothesis, that replacing some fractions of b-PEI by a non-toxic starch would 
enhance the safety of the polymer while retaining the transfection efficiency, could thus be 
verified. The gained results demonstrate the advanced potential of newly developed starch-g-
PEI polymers with superior characteristics as non-viral platform for gene delivery. 
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5.1 Introduction 
For the requirement to improve the transfection efficiency of non-viral gene delivery vector, 
the hydrophobic modification of PEI based polymer and other cationic polymers has been 
studied by several researchers
123
. However the effect of the hydrophobic chain to the 
transfection efficiency is still controversial. Some studies have shown that incorporation of 
hydrophobic chains can improve gene delivery efficiency
124,125,126
, mainly explained by 
hydrophobic interaction conferred to the resulting amphiphilic polycation derivatives and by 
the enhanced cellular uptake by the hydrophobic chains via the lipophilic cell membrane. For 
example, Gabrielson et al.
126
 acetylated PEI 25 kDa and obtained much higher (up to 58-fold) 
transfection efficiency in comparison to original PEI 25 kDa. With 57 % acetylation of 
primary amines of PEI gave the best transfection efficiency, though the buffering capacity of 
the hydrophobic modified PEI was decreased. On the other hand, some have shown the 
decreased transfection efficiency by introducing of the hydrophobic chains
127,128
. Masotti et 
al.
127
 introduced many different hydrophobic chains (lauryl-, myristyl-, cetyl-, lauroyl-, 
myristoyl-, palmitoyl and poly-L-aspartic chains) onto PEI 25 kDa, and observed dramatically 
decreased transfection efficiency, though all the PEI derivatives were able to migrate into the 
cells. Doody et al.
129
 also modified PEI (25 kDa) with acetate, butanoate and hexanoate and 
observed increasing and decreasing transfection efficiency compared to non-modified PEI. 
Over 25 mol% hydrophobic modification onto PEI caused decrease of the transfection 
efficiency. Overall, the different results (positive or negative) from the each study suggested 
that the gene delivery activity would be attributable to an appropriate balance of the 
hydrophobic groups and their introduced amount, which could alter important polymer 
characteristics as gene delivery vector, like buffering capacity and strength of polymer/DNA 
interactions.  
 
In this chapter, we introduced different hydrophobic groups to the selected starch-g-PEI 
polymer, S2M-g-PEI30 synthesized in chapter 3, and studied the effect of the hydrophobic 
modification on particle stability and transfection efficiency. Our hypothesis were; 1) balanced 
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amount of hydrophobic modification could help the stability and cellular uptake of the 
polyplexes, 2) excess of hydrophobic modification decreases the amine termini too much and 
have thus a negative effect. As the modification reaction, we have chosen the amine – 
isocyanate or isothiocyanate reaction. Isocynate groups have extremely high reactivity with 
amine groups through an exothermic reaction. At the same time, isocyanate group has a high 
reactivity with water. Since S2M-g-PEI30 is soluble only in water, we needed to perform this 
reaction in the co-solvent system, H2O/THF. Though isocyanate group has higher reactivity 
with amine group than water, this competing reaction would be a key factor of this 
modification. To avoid this competing reaction, isothiocyanate group was also used. Unlike 
isocyanate, isothiocyanate group is stable in water and it was expected that this stability could 
increase the reaction conversion with amine groups. As hydrophobic groups, we have chosen 
three different C7 structures. Benzyl-, cyclohexylmethyl and heptyl- iso(thio)cyanate (Figure 
23) were selected as the coupling partner of the S2M-g-PEI30. Short and cyclic hydrophobic 
groups were chosen to avoid the steric hindrance and solubility problems with larger and 
aliphatic ones. 
  
 
  
Figure 23: Chemical structures of three different hydrophobic isothiocyanates and 
isocyanate 
 
Benzyl isothiocyanate  
(Benz-ITC) 
Cyclohexylmethyl isothiocyanate 
 (CycHex-ITC) 
Heptyl isocyanate 
 (Hep-IC) 
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5.2 Experimental section 
5.2.1 Materials 
One of the most successful starch-g-PEI polymers from chapter 4, S2M-g-PEI30 was used as 
the starting material of the hydrophobic modification. Three different hydrophobic 
iso(thio)cyanates, benzyl isothiocyanate (Benz-ITC), cyclohexylmethyl isothiocyanate 
(CycHex-ITC) and Heptyl isocyanate (Hep-IC) (Figure 23) were purchased from Sigma-
Aldrich Co. (St. Louis, MO) and used without further purification. Agarose, ethdium bromide 
and the BCA Protein Assay Reagent Kit was purchased from Sigma-Aldrich, as well. Purified 
water is produced by Milli-Q water purification system (Merk Millipore, Billerica, U.S.A.). 
pGL3 pDNA encoding firefly luciferase was prepared and used as described in detail in 
chapter 4. 1 mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer pH 7 
was prepared and stored at 4 °C until use. A549 cells No ACC 107 were purchased from 
DSMZ GmbH (Braunschweig, Germany). Cell culture medium (RPMI 1640) was purchased 
from PAA Laboratories GmbH (Pasching, Austria) and fetal bovine serum (FBS) was 
purchased from Lonza (Basel, Switzerland). The Luciferase assay kit was purchased from 
Promega (WI, U.S.A.).  
 
5.2.2 Hydrophobic modification of starch-graft-PEI polymer 
Hydrophobic modification of S2M-g-PEI30 was performed in co-solvent system, H2O/THF. 
Briefly, 10 mg of S2M-g-PEI30 (containing 3.38 × 10
-3
 mmol PEI) was solubilized in 400 µL of 
purified water and an appropriate amount of hydrophobic isothiocyanate or isocyanate in 100 
µL of THF was quickly added to the S2M-g-PEI30 aqueous solution with stirring. The reaction 
mixture was further stirred for 24 h at R.T. and purified by extraction with water / chloroform 
for five times. The water phase was collected and lyophilized. The resulting white polymers 
were characterized by FT-IR and 
1
H-NMR. Bruker NMR Magnet System 400 MHz Ultra 
shield plus: in D2O, δH Starch: (1H, 5.1 – 5.6 ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), 
PEI: (NH2-CH2-CH2, 2.20 – 3.45 ppm), benzyl group: (aromatic protons, 7.22 – 7.34 ppm), 
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cyclohexyl group (methyl protons, 0.68 – 2.00 ppm), heptyl group (metyl protons, 0.56 – 2.00 
ppm). 
 
 
 
Scheme 7: Hydrophobic modification of starch-g-PEI polymer:  
Reaction with amine group and iso(thio)cyanate group 
 
 
5.2.3 Polyplex formation and characterization 
The stem polymer solutions were prepared by solubilizing the polymers into the purified water 
in the concentration of 1 mg/mL and stored at -20 °C until use. The stem aqueous solution of 
each polymer and pDNA were further diluted with purified water to the suitable concentration 
and incubated for 10 min at 50 °C. An appropriate amount of pDNA (N/P = 10, 12, 14) was 
added to the polymer solution. After the addition of pDNA, the solution was immediately 
mixed for 10 seconds by vortex and incubated for 30 min at R.T. The characterization (size, 
particle homogeneity and zeta potential) of polyplexes was studied by Zetasizer Nano-ZS 
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(Malvern Instruments, Worcestershire, UK) as described in chapter 4, page 51. Additionally, 
the stability of the polyplexes in HBSS buffer was studied to mimic the condition of 
transfection experiment. The polyplex solution was diluted with HBSS buffer 1 : 4 (polyplex 
solution: HBSS buffer) and particle size were measured after 2 and 4 h incubation in the 
buffer. 
 
5.2.4 Luciferase transfection assay 
Transfection efficiency was evaluated with A549 cells. A549 cells were maintained in RPMI 
cell culture medium supplemented with 10 % (v/v) FBS at 37 °C in 5 % CO2. A549 cells were 
seeded in a 24-well plate at a density of 25,000 cells per well in 500 µL of the cell culture 
medium. Polyplexes with luciferase pDNA (pGL3) in Hank's Balanced Salt Solution (HBSS 
buffer) pH 7.4 were added on the cells (1 µg pDNA in 500 µL HBSS buffer pH 7.4 / well). 
After 4h of incubation, the polyplex solution was replaced by cell culture medium and further 
incubated for 48 h. Luciferase gene expression was evaluated using a Luciferase assay kit 
from Promega and the relative light units (RLU) were measured by Tecan microplate reader 
(Tecan Deutschland GmbH, Crailsheim, Germany). Protein quantification was performed with 
BCA assay kit at 570 nm. The transgene expression was normalized for the protein content. 
All the experiments were conducted in duplicate. 
 
5.2.5 Cytotoxicity studies 
LDH and MTT assay were performed to study the in vitro cytotoxicity of the hydrophobic 
modified starch-g-PEI polymers. The A549 cells were seeded in a 96-well plate at a density of 
10,000 cells per well in 200 µL of the cell culture medium. Once confluent, polymers in 
HBSS buffer pH 7.4 were applied on the cells and incubated for 4 h at 37 °C with gently 
shaking. As reference, HBSS buffer (negative, 0%) and 0.1% (w/w) Triton X-100 solution 
(ICN, Eschwege, Germany) (positive, 100%) in HBSS buffer were applied. To ensure the no 
interference of polyplexes to the test system, polyplexes without any cells were also tested.  
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5.2.5.1 LDH assay 
After 4 h incubation of the above-mentioned 96-well plate, the 100 µL of the incubated HBSS 
solution was transferred to another 96-well plate. The 100 µL of LDH test solution (Roche 
Cytotoxicity LDH kit) was added to each well and the plate was incubated in dark for 5 min at 
R.T. The absorbance at 492 nm was read by Tecan microplate reader.  
 
5.2.5.2 MTT assay 
After the 4 h incubation of the above-mentioned 96-well plate, the test solution was removed 
and cells were washed once with HBSS buffer. The fresh HBSS buffer with 10 % (vol.) of 
MTT reagent (5 mg/mL) was added, and incubated further 4 h at 37 °C with gently shaking. 
The solution was removed and cells were dissolved in DMSO and incubated 10 min at 37 °C 
with gently shaking and protected from light. The absorbance at 550 nm was read by Tecan 
microplate reader.  
 
5.2.6 Agarose gel electrophoresis 
To study the DNA-binding/-release ability of the polyplexes, agarose gel electrophoresis was 
used. The polyplexes with appropriate N/P ratio were prepared as described above. 12 µL of 
polyplex (containing 0.12 µg pDNA) solution with/without 5 units of Heparin, were mixed 
with 2 µL of blue dye and loaded into a 0.7 wt% agarose gel containing 0.5 µg/mL ethidium 
bromide. Electrophoresis was run in 0.5 %TBE buffer at 50 V for 75 min. DNA retardation 
was analyzed using UV illuminator, Fusion FX7 imaging system (Peqlab, Erlangen, Germany), 
to show the band of the DNA. 
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5.2.7 Dye displacement assay using Heparin 
For the precise study of the DNA-release ability by heparin competition, the Ethidium 
bromide dye displacement assay was used. The 50 µL of formulated polyplex, described 
above, was placed in the 96-well plate and add 100 µL of 1mM HEPES buffer (pH 7.0) 
containing 1µM Ethidium bromide. The fluorescence (ex: 544nm em: 590nm) of the fully 
complexed pDNA was measured by Tecan microplate reader (Tecan Deutschland GmbH, 
Crailsheim, Germany) and set as the blank value. Titration was performed using heparin 
solution in purified water (40 unit/mL). After every addition of 2 µL of Heparin solution, the 
fluorescence increase by intercalation of Etbr into the released pDNA was measured and 
plotted against the amount of the added heparin. 
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5.3 Results and discussion 
5.3.1 Synthesis and characterization of hydrophobic modified starch-graft-PEI polymers 
The hydrophobic modification of the S2M-g-PEI30 was done by the reaction of the amine-
groups of the S2M-g-PEI30 and isothiocyanate or isocyanate group of the hydrophobic chains 
(Benz-ITC, CycHex-ITC and Hep-IC, Scheme 7). The chemical structures of the resulting 
hydrophobic modification with three different hydrophobic groups are shown in Figure 24. 
 
 
Figure 24: Structures of the three different hydrophobic modified starch-g-PEIs 
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The representative 
1
H-NMR spectra of each hydrophobic modification are shown in Figure 25. 
Bruker NMR Magnet System 400 MHz Ultra shield plus: in D2O, δH Starch: (1H, 5.12 – 5.58 
ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), PEI: (NH2-CH2-CH2, 2.20 – 3.45 ppm), 
benzyl group: (aromatic protons, 7.22 – 7.34 ppm), cyclohexyl group (methyl protons, 0.68 – 
2.00 ppm), heptyl group (metyl protons, 0.56 – 2.00 ppm). 
 
 
 
Figure 25: 
1
H-NMR spectra of each hydrophobic modification 
in D2O, δH Starch: (1H, 5.12 – 5.58 ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), 
PEI: (NH2-CH2-CH2, 2.20 – 3.45 ppm), benzyl group: (aromatic protons, 7.22 – 7.34 
ppm), cyclohexyl group (methyl protons, 0.68 – 2.00 ppm), heptyl group (methyl 
protons, 056. – 2.00 ppm). 
 
 
The amount of the hydrophobic chain introduced in the S2M-g-PEI30 was calculated based on 
the 
1
H-NMR results, the ratio between 1H proton of the starch glucose units (5.12 – 5.58 ppm) 
and each hydrophobic groups´ protons, benzyl group: (aromatic protons, 7.22 – 7.34 ppm), 
cyclohexyl group (methyl protons, 0.68 – 2.00 ppm), heptyl group (methyl protons, 0.56 – 
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2.00 ppm), and summarized in Table 6. As is shown in Table 6, different amount of 
hydrophobic chain in the range of 10 - 200 (mol% against s-PEI side chains) was fed in the 
modification reaction. Thus, Table 6 shows the modification reaction efficacy when 
comparing the feed to the introduced amount (either as mol% against s-PEI side chains or wt% 
against the whole molecule) on the S2M-g-PEI30. The smallest modification amount of the 
Benz-ITC and CycHex-ITC were not detectable in 
1
H-NMR. The conversions of the 
modification by Hep-IC were almost 100 %. We had concerns about the modification using 
isocyanate group because of the side reaction between water and isocyanate. However, the 
results were better than that of isothiocyanate. Because of the higher reactivity between 
isocyanate and amine, the side reaction between isocyanate and water did not occur and 
showed the successful reactions. On the other hand, the reactivity of the isothiocyanate group 
with amine was not high enough to achieve a 100 % conversion. Regarding the structures of 
hydrophobic groups, benzyl- cyclohexylmethyl- and heptyl group, the linear heptyl group 
modification leads to higher conversion than the other two. Since there is no big difference 
among these hydrophobic groups concerning the molecular size and hydrophobicity, the 
highest conversion of heptyl groups was most likely because of the efficient reaction of the 
isocyanate group compared to isothiocyanate group. 
In the following, polymers are named systematically, according to their hydrophobic 
modification amount. The subscript number after each hydrophobic chain (Benz, CycHex and 
Hep) stands for the wt% of the hydrophobic modification against the whole molecule S2M-g-
PEI30-hydrophobic polymer.  
 
Table 6: Results of the hydrophobic modification with three different hydrophobic groups 
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FT-IR measurement was performed to confirm the purification. The typical and strong 
absorbance of the isothiocyanate and isocyanate, at 2076 and 2255 cm
-1
 respectively, was not 
observed in any of the product (Figure 26) that indicated the successful removal of the non-
reacted hydrophobic molecules by the extraction procedure with water / chloroform.  
 
 
Figure 26: IR spectra of the hydrophobic molecules and starch-g-PEI-hydrophobic polymers 
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5.3.2 Polyplex formation and characterization 
Using the synthesized starch-g-PEI-hydrophobic polymers, polyplexes were formed with 
pDNA. In order to see the influence of the hydrophobic modification, the polymer with the 
highest modification of each three hydrophobic chain was used, namely S2M-g-PEI30-Benz3.0, 
S2M-g-PEI30-CycHex2.2 and S2M-g-PEI30-Hep7.1. The size and zeta potential of polyplexes 
were measured using a Zetasizer (Malvern Instruments, Worcestershire, UK) and summarized 
in Table 7. As a comparison, polyplex from S2M-g-PEI30 without hydrophobic modification 
was also formulated and characterized. No big difference between the polyplexes, with and 
without hydrophobic modification, in size, PDI and zeta potential was observed. 
The stability of the polyplexes was further studied in HBSS buffer which is used for 
transfection experiment. The polyplex solution was diluted with HBSS buffer five times and 
measured sizes using a Zetasizer. As is shown in Figure 27, the polyplex from S2M-g-PEI30-
Benz3.0 and S2M-g-PEI30-CycHex2.2 showed a little decreased stability over the time in HBSS. 
On the other hand, S2M-g-PEI30-Hep7.1 showed better stability, though having higher PDI, 
indicating a broader size distribution. However the difference was not so big and all 
polyplexes were stable enough for transfection, as they remained below 200 nm size after 4 h 
incubation in the buffer. Thus, no huge effect of the hydrophobic modification was found from 
these polyplex characterizations with Zetasizer. 
 
 
Table 7: Characterization of the polyplexes from starch-g-PEI-hydrophobic polymers 
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Figure 27: Polyplex stability in HBSS buffer 
 
 
5.3.3 Luciferase transfection assay 
Although, no apparent effect was found in the polyplexes between the absence or presence of 
the hydrophobic modification on the starch-g-PEI, the luciferase transfection assay was 
performed to elucidate any difference in the transfection efficacy.. The polyplexes were 
formulated as described before (N/P = 10, 12 and 14) and transfection efficiency was studied 
with A549 cells.  
In Figure 28, the results of the luciferase transfection assay using all three different 
hydrophobic modifications are shown. As is easily recognized, the transfections from 
hydrophobic modified samples were decreased. The more hydrophobic modification, the less 
transfection was observed. The same tendency was seen in all three hydrophobic chain 
modified samples. It became clear that, the hydrophobic modification on the starch-g-PEI, 
unfortunately, did not increase but decrease the transfection efficiency. Focusing on the S2M-
g-PEI30-Hep series (Figure 28(c)), the amount of the heptyl group to the whole molecular 
weight is 0.5, 2.1, 4.0 and 7.1 wt%. Taking this amount into account, the effect of the 
hydrophobic chain on the transfection efficiency is really huge. Only 0.5 wt% of heptyl groups 
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did already decrease the transfection efficiency, and 4.0 and 7.1 wt% heptyl group modified 
samples resulted in almost no transfection any more. 
 
Figure 28: Results of luciferase transfection assay with different hydrophobic modification 
(a) S2M-g-PEI30-Benz, (b) S2M-g-PEI30-CycHex, (c) S2M-g-PEI30-Hep 
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5.3.4 Cytotoxicity studies 
The negative effect of the hydrophobic chain on the transfection efficiency became clear. To 
find out the cause of this decrease in transfection efficiency, cytotoxicity studies were 
performed. Only the highest hydrophobic modification of each hydrophobic group (S2M-g-
PEI30-Benz3.0, S2M-g-PEI30-CycHex2.2 and S2M-g-PEI30-Hep7.1) was tested and compared with 
the non-hydrophobic modified S2M-PEI30 and PEI 25 kDa. In LDH assay, no big difference 
between hydrophobic modified and unmodified polymers were observed at lower 
concentrations (< 50 µg/mL), however in higher concentrations (> 100 µg/mL) the benzyl and 
heptyl group modified polymer showed obviously higher cytotoxicity than S2M-PEI30 (Figure 
29 (a)). The higher cytotoxicity of hydrophobic modified polymers than non-hydrophobic 
modified polymer was more easily recognized in MTT assay (Figure 29 (b)). However, in 
comparison to PEI 25 kDa, all the hydrophobic modified polymers showed still lower 
cytotoxicity. Therefore, one of the reasons of the decreased transfection efficiency would be 
the increased cytotoxicity though it would not be the only reason, since the cytotoxicity of the 
hydrophobic modified polymers were not as critical as that of PEI 25 kDa (Figure 29). 
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Figure 29: Cytotoxicity study, (a) LDH and (b) MTT assay 
 
 
5.3.5 Agarose gel electrophoresis 
The DNA-binding ability of the polyplexes was tested using agarose gel electrophoresis to see 
the difference between hydrophobic modified/unmodified starch-g-PEI polymers. At the same 
time, DNA releasing ability was tested by adding the strongly negative charged molecule 
heparin to the polyplexes and run an electrophoresis.  
In Figure 30, several small differences between the samples with and without hydrophobic 
modifications were observed. All polymers could make nice polyplexes and no free, 
uncomplexed pDNA was observed without the addition of the heparin (Figure 30 a, b, c and d). 
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However, the fluorescence of pDNAs with hydrophobic modified samples (b, c, and d) were 
brighter than without hydrophobic modification (a). That indicated the ethidium bromide 
could intercalate into pDNA stronger in the polyplexes with hydrophobic chains. In other 
words, the starch-g-PEI without hydrophobic chain has stronger binding ability with pDNA 
than the polymers with hydrophobic chains. By the addition of the heparin (Figure 30, 
alphabets with apostrophe), pDNA-polymer complexes were broken and free pDNA ran 
through the agarose gel. The clear pDNA band was visible by means of ethidium bromide.  
Polyplex from S2M-g-PEI30-Hep7.1  (d)´ showed the less pDNA release than the other samples 
(a)´, (b)´ and (c)´, which would fit with the results of HBSS-stability measurement (Figure 27). 
 
 
 
 
Figure 30: Agarose gel electrophoresis with and without hydrophobic modification:  
M: marker, pDNA: not complexed, free pDNA (a) S2M-g-PEI30, (b) S2M-g-PEI30-
Benz3.0, (c) S2M-g-PEI30-CycHex2.2, (d) S2M-g-PEI30-Hep7.1, Alphabets with apostrophe 
were after the addition of 5 unit heparin 
 
 
5.3.6 Dye displacement assay using Heparin 
For the precise study of the DNA release by heparin competition, the dye displacement assay 
was used. The titration was performed with the addition of heparin (each 0.08 unit) and 
+ Heparin 
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fluorescence measurement (ex: 544nm em: 590nm) by a microplate reader. In Figure 31, the 
fluorescence intensity was plotted against the added amount of the heparin (unit). The release 
of pDNA from all three hydrophobic modified polyplexes were faster than that of S2M-g-PEI30 
polyplex. That means negatively charged heparin could more easily destroy the polyplexes 
from hydrophobic modified polymers. Hence, it is conceivable that the hydrophobic 
modification weakened the interaction between pDNA, and the DNA-binding ability of the 
hydrophobic modified samples decreased in comparison to that of S2M-g-PEI30. This slight 
difference between the hydrophobic modified polyplexes and non-hydrophobic modified 
polyplex was difficult to see in polyplex characteristics in size, PDI and zeta-potential by 
means of Zetasizer, but could be observed in this titration study and also the agarose gel 
electrophoresis. Comparing these three hydrophobic samples, the S2M-g-PEI30-Hep7.1 carried 
more hydrophobic groups (less free amine groups left), however showed not much faster in 
pDNA release. Thus, it would be reasonable to conclude that there was still a small 
stabilization effect of the Hep-chains that was acting against the decreased number of primary 
amines. The dramatic decrease of the transfection efficiency in luciferase assay is most likely 
a combined effect caused by the slight increase in cytotoxicity (compared to S2M-gPEI30), the 
increased complex stability in HBSS, which leads to a lower amount of complexes getting in 
contact with the cell in the transfection experiment and the faster release of pDNA due to the 
decreased number of primary amines.  
Our expectation before this study was that the hydrophobic chain would increase the polyplex 
stability because of the micelle effect (Figure 32 (a)) and increase the transfection efficiency. 
Yet the effects were unlike. A possible explanation for this could be that the chosen 
hydrophobic chains are not long enough to allow self-assembly of the amphipilic molecules in 
stable structures (Figure 32 (a)), though heptyl modification seems to be more efficient than 
the cyclic ones. The complex branched structure of the starch-g-PEI-hydrophobic polymers 
could also be a cause. It is known that the stiffness of branched polymers, which are composed 
of a main chain and side chains, would increase by increasing density and length of the side 
chains
130
. Those polymers do not behave as worm-like chain any more in a good solvent, and 
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repulsions between the main chain and side chains, and between neighboring side chains 
makes the high stiffness of this branched polymer. Since both of the starch and s-PEI have 
branched structures, the starch-g-PEI was expected to have certain stiffness. Though the 
density of the side chains (amount of the modification) is not so high, every 12
th
 glucose 
carries a s-PEI side chain, the size of the s-PEI (800 Da) was expected enough large to 
increase the stiffness of starch. Thereby, the introduced hydrophobic chains did not have a 
freedom to move and could not exist central part of the polyplex but dispersed all of the 
polyplex structure (Figure 32 (b)). The dispersed hydrophobic chain could interfere the 
compact and tight electrostatic interaction between amine groups and pDNA, and decrease the 
DNA-binding ability. In that context, the hydrophobic group deemed to a defect. Thus, the 
more hydrophobic chain caused the more defect, weaken the DNA-binding ability, unstabilize 
the polyplex and decrease the transfection efficiency. 
 
 
 
 
Figure 31: Titration curves for DNA  release 
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Figure 32: Polyplex structure, with and without the hydrophobic modification 
 
 
Another explanation of the decreased transfection would be the loss of the primary amine 
groups because of the reaction with isothiocyanate or isocyanate groups of the hydrophobic 
groups. One s-PEI side chain (800 Da) has around 5 - 1 = 4 primary (1 primary amine group 
was already used in the reaction with starch backbone), 10 secondary and 5 tertiary amine 
groups. If one of the primary amine groups of the each s-PEI side chain is reacted with 
iso(thio)cyanate, the amount of the primary amine group of the whole molecule becomes 75 %. 
The amount of the primary amine groups of the each hydrophobic modified polymer 
compared with S2M-g-PEI30 is, S2M-g-PEI30-Benz3.0 = 79 %, S2M-g-PEI30-CycHex2.2 = 86 %, 
S2M-g-PEI30-Hep7.1 = 53 %. This loss of the primary amine group could also cause the 
decrease of the binding ability with pDNA and polymer and decrease the transfection 
efficiency. This result fit with other reported studies
131,132
 which demonstrated the decreased 
transfection efficiency caused by the reduced number of primary amine groups. In conclusion, 
the true cause of decreased transfection efficiency was not one but combination of the whole 
explained matters. 
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5.4 Conclusion 
The successful hydrophobic modification of the S2M-g-PEI30 has been done using three 
different hydrophobic molecules, Benz-ITC, CycHex-ITC and Hep-IC. The conversion of the 
hydrophobic modification with isocyanate group were around 100 % and worked better than 
that of isothiocyanate groups (conversion = around 25 – 50 %). 
Polyplexes were formulated using the hydrophobic modified polymers. Compared with the 
polyplex of S2M-g-PEI30, no significant difference was observed in size, PDI, zeta-potential, 
but a slightly altered stability in HBSS buffer.  
However hydrophobic modification gave the remarkable effect to the transfection efficiency. 
The more hydrophobic modification, the less the luciferase transfection efficiency was 
observed. Only few weight percent of the hydrophobic groups were enough to decrease the 
transfection efficiency. 
To study the cause of this decreased transfection efficiency, pDNA-binding and release ability 
was investigated by agarose gel electrophoresis and dye displacement assay using ethidium 
bromide and heparin. It became clear that the DNA-binding ability of the hydrophobic 
modified polymers were decreased compared to S2M-g-PEI30. The release of the pDNA in 
hydrophobic modified polyplexes was faster than S2M-g-PEI30. The reason of this weakened 
DNA-binding ability were assumed to be two points; 1) the interference of the DNA-amine 
electrostatic interaction by hydrophobic chain (Figure 32 (b)), and 2) the loss of the primary 
amine groups which should have electrostatic interaction with pDNA. 
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6.1 Introduction 
In their attempts to develop improved gene delivery vectors, many researchers have 
synthesized cationic polymers, which aimed to mimic PEI 25 kDa as model structure. For that 
purpose, oligoamines are occasionally  used
133, 134, 135, 136
. Lin et al.
134
 introduced different 
linear oligoamines, namely, ethylenediamine (EDA), dietylenetriamine (DETA), 
triethylenetetramine (TETA), tetraethylenepentamine (TEPA), dipropylenetriamine and 
spermine onto the disulfide-amide polymer backbone and synthesized bioreducible 
poly(amido amine)s. The synthesized poly(amido amine)s showed different characteristics 
depending on the side chains. The increased alkyl spacer from ethylene to propylene between 
the amino units in side chains resulted in significantly lower transfection efficiency. 
Srinivasachari et al.
135
 also used linear oligoamines, either DETA, TETA, TEPA, or 
pentaethylenehexamine (PEHA) to modify β-cyctodextrine. All synthesized polymers showed 
good transfection efficiency and low cytotoxicity, without significant differences from the 
different side chain. Wei et al.
136
 synthesized poly-(glycidyl methacrylate) by RAFT 
polymerization and decorated with three different types of oligoamines, i.e., TEPA, PEHA, 
and tris(2-aminoethyl)amine (TREN), respectively. With respect to the transfection efficiency 
and cytotoxicity, they concluded that the TEPA is the best side chain for this polymer. Some 
works of the peptide modification with oligoamines were also published
137, 138
. Salcher et al.
138
 
used three different oligoamines, TETA, TEPA and PEHA to modify peptide (oligoamino 
acid) and proved a clear preference of the oligoamines, in the order of PEHA>TEPA>>TETA 
for pDNA compaction and transfection efficiency. The modification of carbohydrate backbone 
was also studied by some researchers
109, 139
. Amylopectin modification
109
 and chitosan 
modification
139
 were done with several oligoamines. The synthesized polymers showed good 
cytotoxic properties, however the transfection efficiency was not more than PEI 25 kDa. 
 
In this chapter, we studied the effect of different oligoamines side chains on the starch 
backbone. The intention was to replace the s-PEI (0.8 kDa) side chains of starch-g-PEI from 
chapter 4 with smaller MW cationic side chains in order to achieve lower cytotoxicity and, if 
Starch-graft-cationic polymers: Comparison of PEI side chain and small MW side chains   
90 
possible, maintain a similar level of transfection efficiency. Figure 33 depicts the used 
oligoamines, namely, dietylenetriamine (DETA), tetraethylenepentamine (TEPA) and tris(2-
aminoethyl)amine (TREN).  
The question to be answered by this study was which cationic side chain can best combine the 
two main properties of low cytotoxicity and high transfection efficiency, and how this 
compares with the starch-g-PEI from chapter 4.  For a systematical study of different size and 
structure of the side chain, we selected three different oligoamines, DETA, TEPA and TREN. 
These three molecules have same repeating units to PEI, -CH2CH2NH-, which is accounted for 
the “proton sponge” effect to enable endosomal escape. Two of them, DETA and TEPA are 
linear structure which MW are 103.17 g/mol and 189.30 g/mol respectively, and TREN has 
branched structure as well as s-PEI with MW of 146.23 g/mol (Figure 33). Through the 
comparative study of these three different molecules and s-PEI, we aimed to learn important 
structural characteristics of successful side chains. 
 
 
 
Figure 33: Chemical structures and MW of three different oligoamine side chains 
 
 
TEPA (MW = 189.30 g/mol) 
DETA (MW = 103.17 g/mol) 
TREN (MW = 146.23 g/mol) 
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Since the results in chapter 4 showed the superior potential of the larger MW starch backbone, 
only large MW (> 290,000 g/mol) of the oxidized starch backbones were used for the study in 
this chapter, and modified with three different oligoamines. The ability of the resulting three 
new starch-g-polymers as a gene delivery vector was then, compared with PEI 25 kDa, a 
commercial transfection reagent and the best polymer in chapter 4, namely S2L-g-PEI30 as 
benchmarks. 
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6.2 Experimental section 
6.2.1 Materials 
Large molecular weight (MW > 290,000 g/mol) of the partially oxidized potato starch, 
synthesized according to chapter 3, was used as the backbone of the cationic polymers. Two 
different MW branched polyethylenimine, (b-PEI, 25 kDa) (s-PEI, 0.8 kDa) and three 
different small cationic side chains, dietylenetriamine (DETA), tetraethylenepentamine 
(TEPA), tris(2-aminoethyl)amine (TREN) were purchased from Sigma-Aldrich Co. (St. Louis, 
MO) and used without further purification. 2-Chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) 
and 4-Methylmorpholine (NMM) were purchased from Sigma-Aldrich Co. Purified water is 
produced by Milli-Q water purification system (Merk Millipore, Billerica, U.S.A.). pGL3 
pDNA encoding firefly luciferase and another pDNA encoding fluorescent protein AmCyan 
were prepared and used as detailed in chapter 4. A transfection reagent, jetPRIME
TM
 was 
purchased from Polyplus transfection (Illkirch, France). A549 cells No ACC 107 were 
purchased from DSMZ GmbH (Braunschweig, Germany). Cell culture medium (RPMI 1640) 
was purchased from PAA Laboratories GmbH (Pasching, Austria) and fetal bovine serum 
(FBS) was purchased from Lonza (Basel, Switzerland). The Luciferase assay kit was 
purchased from Promega (WI, U.S.A.). The BCA Protein Assay Reagent Kit was purchased 
from Sigma-Aldrich. 
 
6.2.2 Synthesis and characteristics of the starch based cationic polymers 
The reaction between sodium carboxylate groups of Starch and amine groups of DETA, TEPA 
or TREN were done according to Kunishima et al.
113
 (Scheme 8). Briefly, Large MW of the 
oxidized starch from chapter 3 (500 mg, 1.66 mmol sodium carboxylate) was solubilized in 50 
mL of solvent mixture (1 : 4 = purified water : DMSO) in a round-bottomed flask followed by 
the addition of 1.99 mmol conjugation reagent, 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4methyl-
morpholinium Chloride (DMTMM), while stirring. The reaction mixture was stirred for 30 
min. in R.T. to activate the sodium carboxylate groups. Subsequently, 166 mmol of amino 
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functionalized compound, either DETA, TEPA or TREN in 100 mL of solvent mixture (1 : 4 = 
purified water : DMSO) was slowly added. The reaction was proceeded with stirring for 72 h 
at R.T. and extensively dialyzed (3.5 kDa Mw cutoff, regenerated cellulose membrane, Fisher 
scientific) against purified water. The water insoluble white precipitation was removed by 
filtration and the reaction solution was collected and lyophilized. The amount of cationic side 
chains (wt%) on the starch backbone was determined by 
1
H-NMR. Bruker NMR Magnet 
System 400 MHz Ultra shield plus: in D2O, δH Starch: (1H, 5.12 – 5.58 ppm), (2H, 3H, 4H, 
5H, 6H, 3.45 – 4.30 ppm), DETA, TEPA, TREN: (NH2-CH2-CH2, 2.29 – 3.46 ppm). The 
purity of starch based cationic polymers were examined by GPC measurement (HLC-
8320GPC, Tosoh, Japan) on SUPREMA-MAX 1000 and 30 columns (PSS) at a flow rate 1 
mL/min at 35 °C in 1 % formic arid. 
 
 
 
Scheme 8: Synthesis of the starch based cationic polymers using different cationic 
side chains 
 
6.2.3 Polyplex formation 
The stem polymer solutions were made by solubilizing the polymers into the purified water in 
the concentration of 1 mg/mL and stored at -20 °C until use. The stem aqueous solution of 
each polymer and pDNA were further diluted with HEPES buffer (pH 7 with 5 wt% glucose) 
to the suitable concentration and incubated for 10 min at 50 °C. An appropriate amount of 
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pDNA (N/P = 2 - 40 : ratio between nitrogen of polymer and phosphate of pDNA) was added 
to polymer solution. After the addition of pDNA, the solution was immediately mixed for 10 
seconds by vortex and incubated for 30 min at R.T. 
 
6.2.4 Polyplex characterization 
The characterization (size, particle homogeneity and zeta potential) of polyplexes was studied 
by Zetasizer Nano-ZS (Malvern Instruments, Worcestershire, UK) as described in chapter 4, 
page 51.  
 
6.2.5 Transfection experiments 
Transfection efficiency was evaluated with A549 cells. A549 cells were maintained in RPMI 
cell culture medium supplemented with 10 % (v/v) FBS at 37 °C in 5 % CO2. 
 
6.2.5.1 Luciferase transfection assay 
A luciferase assay was used for the screening of transfection efficiency because of the high 
throughput and sensitivity of the assay. A549 cells were seeded in a 24-well plate at a density 
of 25,000 cells per well in 500 µL of the cell culture medium. Polyplexes with luciferase 
pDNA (pGL3) in Hank's Balanced Salt Solution (HBSS buffer) pH 7.4 were added on the 
cells (1 µg pDNA in 500 µL HBSS buffer pH 7.4 / well). After 4h of incubation the polyplex 
solution was replaced by cell culture medium and further incubated for 48 h. Luciferase gene 
expression was evaluated using a Luciferase assay kit from Promega and the relative light 
units (RLU) were measured by Tecan microplate reader (Tecan Deutschland GmbH, 
Crailsheim, Germany).  Protein quantification was performed with BCA assay kit at 570 nm. 
The transgene expression was normalized for the protein content. All the experiments were 
conducted in duplicate. The results were depicted as mean value ± SD. Significance among the 
mean values was calculated using Student’s t-test. Probability value p < 0.01 was considered 
significant. 
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6.2.5.2 Flow cytometry 
The amount of transfected cell was determined by flow cytometry. A549 cells were seeded in 
a 12-well plate at a density of 20,000 cells per well in 1 mL of the cell culture medium. 
Polyplexes with pDNA encoding fluorescent protein AmCyan in HBSS buffer pH 7.4 were 
added on the cells (2 µg pDNA in 1 mL HBSS buffer pH 7.4 / well), and incubated 4 h. After 
the incubation, the polyplex solution was replaced by cell culture medium and incubated for 
further 48 h. The cells were washed three times with PBS, collected and centrifuged at 1,400 
rpm for 4 min. The resulting cell pellet was suspended in 500 μL of cell culture medium and 
analyzed by flow cytometry, with excitation by argon laser at 488 nm and emission through 
the 515 – 545 nm filter. 10,000 cells per sample were analyzed using BD FACSCaliburTM 
(Becton-Dickinson, Heidelberg, Germany). The percentage of cell-associated ﬂuorescence 
was determined using the computer program FlowJo (version 7.2.5, Tree Star, Stanford, CA). 
All the experiments were conducted in duplicate. The results were depicted as mean value ± 
SD. Significance among the mean values was calculated using Student’s t-test. Probability 
value p < 0.01 was considered significant. 
 
6.2.6 Agarose gel electrophoresis 
To study the DNA-binding and –release ability of the polyplexes, agarose gel electrophoresis 
was used. The polyplexes with appropriate N/P ratio were prepared as described above. 12 µL 
of polyplex (containing 0.12 µg pDNA) solution with/without 5 units of Heparin, were mixed 
with 2 µL of blue dye and loaded into a 0.7 wt% agarose gel containing 0.5 µg/mL ethidium 
bromide. Electrophoresis was run in 0.5 %TBE buffer at 50 V for 75 min. DNA retardation 
was analyzed using UV illuminator, Fusion FX7 imaging system (Peqlab, Erlangen, Germany), 
to show the band of the DNA. 
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6.2.7 Endosome buffering capacity measurements 
The endosome buffering capacities of three different side chains and synthesized polymers 
were measured by the acid-base titration according to Kim et al.
140
. As a comparison, the 
buffering capacities of two different MW PEIs, (25 kDa and 0.8 kDa) were also measured. 
10 mg of each material was dissolved in 10 mL of 0.1 M NaCl solution and adjust pH 11 with 
1 M NaOH. Then the solution was titrated to pH 3 with 0.1 M HCl. After each addition (50 or 
100 µL) of HCl, the pH was measured by CG 843 P pH meter (Schott Geräte GmbH, Hofheim 
am Taunus, Germany) and plotted against the amount of the added HCl. Endosome buffering 
capacity was calculated as percentage of amine groups becoming protonated within the pH-
range from 7.4 to 5.1, according to the following equation: 
 
                   ( )   
          
    
      ( ) 
 
ΔHCl is the volume of HCl solution (0.1 M) which was needed for the titration from pH 7.4 to 
5.1. N mol is the total moles of protonable amine groups in 10 mg of each sample. 
 
6.2.8 Cytotoxicity studies 
MTT assay was performed to study the in vitro cytotoxicity of the starch-g-PEI polymers and 
their complexes. The cytotoxicity of starch based cationic polymers after the 3h incubation 
with α-amylase was also investigated. The A549 cells were seeded in a 96-well plate at a 
density of 10,000 cells per well in 200 µL of the cell culture medium. Once confluent, 
polymers in HBSS buffer pH 7.4 were applied on the cells and incubated for 4 h at 37 °C with 
gently shaking. After the incubation, the test solution was removed and cells were washed 
once with HBSS buffer. The fresh HBSS buffer with 10 % (vol.) of MTT reagent (5 mg/mL) 
was added, and incubated further 4 h at 37 °C with gently shaking. The solution was removed 
and cells were dissolved in DMSO and incubated 10 min at 37 °C with gently shaking. The 
absorbance at 550 nm was read by Tecan microplate reader. As reference, HBSS buffer 
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(negative, 0%) and 0.1% (w/w) Triton X-100 solution (ICN, Eschwege, Germany) (positive, 
100%) in HBSS buffer were applied. To ensure the no interference of polymer to the test 
system, polymers without any cells were also tested. 
 
6.2.9 Biodegradability study by α-amylase 
6.2.9.1 Starch-iodine colorimetric assay 
Biodegradability study of synthesized starch based cationic polymers was performed 
according to Xiao et al.
120
. Briefly, 40 µL of polymer solution (2 mg/mL in purified water) 
was added into 96-well plate. Then, 40 µL of α-amylase solution (25 – 125 µunit/mL in 0.1 M 
phosphate buffer pH 7) was added to each well. The plate was then incubated for 15, 30, 45, 
60, 75 and 90 min at 37 °C and the digestion was stopped by adding 20 µL of 1 M 
hydrochloric acid. Subsequently, 100 µL of iodide color reagent was added and the 
absorbance at 580 nm was read by Tecan microplate reader. Calibration curves were made 
concurrently with experiments for each sample. All the experiments were conducted in 
triplicate. The remaining starch amount in the each sample was calculated using the 
calibration curve and plotted against the incubation time with α-amylase. 
Starch-graft-cationic polymers: Comparison of PEI side chain and small MW side chains   
98 
6.3 Results and discussion 
6.3.1 Synthesis and characteristics of the starch based cationic polymers 
The conjugation reaction between sodium carboxylate groups of the oxidized starch and amino 
groups of DETA, TEPA or TREN were done with the established method in chapter 3 using 
DMTMM conjugation reagent (Scheme 8). The chemical structures using three different 
cationic side chains are shown in Figure 34. 
 
 
 
Figure 34: Starch based cationic polymers with different cationic side chains 
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The Mw and DSCOONa of the oxidized starch, which are used for the conjugation reaction, were 
summarized in Table 8. 
 
 
Table 8: Characteristics of the large MW starch backbones for the conjugation reaction 
 
 
 
By using two starch backbones with different DSCOONa (Table 8), several polymers with 
different amount of the cationic side chain modification were synthesized. The modified 
amount of cationic side chains (wt%) on the starch backbone was determined by 
1
H-NMR. 
Bruker NMR Magnet System 400 MHz Ultra shield plus: in D2O, δH Starch: (1H, 5.12 – 5.58 
ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), DETA, TEPA, TREN: (NH2-CH2-CH2, 2.29 – 
3.46 ppm). In Figure 35, 
1
H-NMR spectra of different amine grafted starches are shown. The 
peaks in the region of 2.29 – 3.46 ppm corresponding to the amine modification, NH2-CH2-
CH2, were observed in all polymers. In the following, polymers are named with a systematic 
name, according to the used starch backbone (S4L or S5L), their side chains and modification 
amount. The subscript number after each oligoamine side chain (DETA, TEPA and TREN) 
stands for the wt% of the side chain against the whole molecule. The purity of starch based 
cationic polymers were examined by GPC measurement (HLC-8320GPC, Tosoh, Japan) on 
SUPREMA-MAX 1000 and 30 columns (PSS) at a flow rate 1 mL/min at 35 °C in 1 % formic 
arid.  
In Figure 36, the GPC curves of pure TEPA and synthesized S5L-g-TEPA28, as representative 
samples were shown. Since there is no peak of free TEPA observed in S5L-g-TEPA28, it 
became clear the purification of excess amount of TEPA by dialysis worked successfully. The 
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GPC curves of all starch-graft-oligoamines showed monomodal peak with polydispersity of 
1.39 to 1.52, which indicated the successful conjugation reaction between oligoamine side 
chains and the starch backbone. 
 
 
 
Figure 35: 
1
H-NMR spectra of the synthesized cationic polymers 
δH Starch: (1H, 5.12 – 5.58 ppm), (2H, 3H, 4H, 5H, 6H, 3.45 – 4.30 ppm), DETA, 
TEPA, TREN: (NH2-CH2-CH2, 2.29 – 3.46 ppm). 
 
 
 
Figure 36: GPC spectra of pure TEPA and S5L-g-TEPA28 
Starch-graft-cationic polymers: Comparison of PEI side chain and small MW side chains   
101 
In Table 9, the characterization results of the synthesized starch based cationic polymers are 
summarized. Three different cationic modifications have been done based on the S5L starch. 
By using the TEPA and TREN side chains, a modification of approximately 30 wt% was 
achieved, which was the target value, since starch-graft-PEI with 30 wt% modification 
showed the best transfection ability (compare chapter 4). However the modification with 
DETA was only 24.4 wt%. This is due to the smaller MW of DETA (MW = 103.17 g/mol) 
compared to other two side chains (MW = 189.30, 146.23 g/mol). Additionally the 
modification of S4, the starch with lower DSCOONa, was done with TEPA, and resulted in a 
modification amount of 23.6 wt%. Every 3.7th glucose of S4L-g-TEPA24, every 1.9th glucose 
of S5L-g-DETA24, every 2.9th glucose of S5L-g-TEPA28 and every 2.2th glucose of S5L-g-
TREN28 has a conjugated cationic side chain. All four polymers showed a monomodal peak in 
GPC and the PDs were around 1.5, which were even smaller than that of starch-graft-PEI 
polymers, indicated the better homogeneity of the starch-graft-oligoamine polymers. The 
successful transfer of the synthesis method developed for PEI to the oligoamines was proofed. 
The time needed for the purification became shorter, since the oligoamine side chains were 
smaller and easier to remove through the dialysis membrane. The obtained starch-graft-
oligoamines were white powder and well soluble in water, those were the same properties that 
obtained starch-graft-PEI polymers.  
 
 
Table 9: Characterization of the synthesized starch based cationic polymers 
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6.3.2 Polyplex formation 
Using the synthesized four different starch based cationic polymers, polyplexes were 
formulated with pDNA (N/P = 18). The size and zeta potential of polyplexes were measured 
using a Zetasizer (Malvern Instruments, Worcestershire, UK) and summarized in Table 10.  
The largest polyplex, 164nm, was observed from S5L-g-DETA24, which has the smallest side 
chain MW and less modification (24 wt%). In general, larger side chains and higher 
modification  lead to  smaller polyplexes with  higher zeta potential. S4L-g-TEPA24 showed a 
little larger size and lower zeta potential polyplex (87 nm, +26 mV) than S5L-g-DETA24 (78 
nm, + 35 mV), which has its reason most likely in the larger starch backbone with higher PD. 
The polplexes from S5L-g-TEPA28 and S5L-g-tirsAm28 showed almost same characteristics, 
the smallest sizes, 70 to 80 nm and highest zeta potentials around + 35 mV. These polyplex 
characteristics of S4L-g-TEPA24, S5L-g-TEPA28 and S5L-g-tirsAm28 were comparable to that of 
S2L-g-PEI30 polymer, which showed the best transfection efficiency in chapter 4. The polyplex 
characterisics also fit the properties reported for good cellular uptake
121
. 
 
 
Table 10: Characterization of the polyplexes from synthesized starch based cationic polymers 
(N/P = 18) 
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6.3.3 Transfection experiments 
The transfection efficiency of the polyplexes from synthesized polymers was studied in the 
A549 cell line.  
6.3.3.1 Luciferase transfection assay 
As first transfection study, the luciferase transfection assay has been performed. From each of 
the four polymers, polyplexes in the N/P range 2 to 40 were formulated and tested for their 
transfection efficiency. PEI 25 kDa (N/P = 10) according to Boussif et al.
44
 were always used 
as positive control. 
In Figure 37, a clear difference between the four polymers was observed. The transfection 
efficiency using the polymers with TEPA side chains (a and c) were much higher than that of 
DETA or TREN (b and d). Though the amount of the cationic modification is almost equal in 
(a) 23.6 % of TEPA side chains and (b) 24.4 % of DETA side chains, the transfection results 
showed a huge difference (Figure 37 (a) (b)). It was assumed that, the characteristic of 
different side chain would bring this huge difference. Both TEPA and DETA are linear 
structures, and their difference could be seen in their MWs, 189.30 and 103.17 g/mol, 
respectively (Figure 33). From this result, it could be demonstrated that the MW of the side 
chain is one of the key factors for the ability as gene delivery vectors. Regarding the Figure 37 
(c) and (d), a similar discussion can be applied. The amount of the cationic modification is 
almost equal, (c) 28.4 % of TEPA side chains and (d) 28.3 % of TREN side chains, and the 
MWs of these two starch based cationic polymers are also the same. Therefore, the cause of 
the huge difference in transfection efficiency was related to the side chains. Here we have two 
different molecular structures, a linear structure in TEPA and a branched structure in TREN. 
Additionally the MW of the both molecules is a little different, 189.30 and 146.23 g/mol, 
respectively (Figure 33). Hence, the difference in transfection efficiency could be caused by 
the MW difference and structural difference of the side chains. From these results of the 
luciferase transfections using three different oligoamine side chains, we could learn; 1) the 
DETA is too short to mediate efficient transfection, and 2) the branched structure, more 
precisely, tertiary amine group is not essential for the good transfection efficiency. 
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The two cationic starches with very promising results, S4L-g-TEPA24 and S5L-g-TEPA28, were 
further studied to find out the optimal N/P ratio in the range of N/P = 16 to 30. We included 
two additional positive controls, the commercial transfection reagent jetPRIME
TM
 and the best 
starch-g-PEI polymer from chapter 4, S2L-g-PEI30 (N/P = 14). 
 
 
 
Figure 37: Results of luciferase transfection assay: 
(a) S4L-g-TEAP24, (b) S5L-g-DETA24, (c) S5L-g-TEPA28, (d) S5L-g-TREN28 
 
 
As is evident from Figure 38, the optimal N/P ratio for the best luciferase transfection 
efficiency was 18 for both polymers. In optimized conditions, both polymers showed higher 
transfection efficiency than the all three positive controls, jetPRIME
TM
, PEI 25 kDa and S2L-
g-PEI30. These excellent results of S4L-g-TEPA24 and S5L-g-TEPA28 indicated that TEPA is 
more suitable as a side chain than s-PEI. As we discussed, the MW of the cationic side chain is 
an essential factor as a good gene delivery vector. The MWs of DETA and TREN were not 
large enough, however too large MW side chain, s-PEI (800 Da), was also not perfect, and it 
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should be somewhere in between, in this case TEPA (MW = 189.30) was the best. At the same 
time, the existence of the tertiary amine groups is not a prerequisite, since not only TREN but 
also s-PEI with a lot of tertiary amine groups showed less transfection efficiency than TEPA. 
 
Based on the results presented in the luciferase transfection assay (Figure 37 and Figure 38), 
the TEPA modified starch, S4L-g-TEPA24 and S5L-g-TEPA28, were chosen as the two best 
candidates for gene delivery vectors and were further studied by flow cytometry. 
 
 
 
Figure 38: Results of luciferase transfection assay (N/P = 16 to 30);  
(a) S4L-g-TEPA24, (b) S5L-g-TEPA28  
Values are the mean + SD from n = 4 measurements.  
Statistical significance is indicated as follows: * (p < 0.01) 
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6.3.3.2 Flow cytometry 
The transfection efficiency of S4L-g-TEPA24 and S5L-g-TEPA28 with N/P = 18 was further 
studied with flow cytometry, to determine the percentage of transfected cells (Figure 39).  
The highest amount of transfected cells, 33 % and 27 %, were observed from the TEPA 
modified starches, S5L-g-TEPA28 and S4L-g-TEPA24. They transfected more cells than any 
other positive controls, jetPRIME (24 %), PEI 25 kDa (13 %), and S2L-g-PEI30 (16 %) (Figure 
39). This was the same tendency as observed in the luciferase transfection experiment, and   
thus verification that TEPA was the superior side chain within all tested candidates with 
respect to the transfection efficiency. 
 
 
Figure 39: Results of Flow cytometry 
Values are the mean + SD from n = 4 measurements.  
Statistical significance is indicated as follows: * (p < 0.01). 
 
 
In Figure 40, Flow cytometry results are shown in the histograms of cell counts against 
fluorescence intensity to compare the different transfection characteristics between s-PEI 
modified starch (S2L-g-PEI30) and TEPA modified starch (S5L-g-TEPA28). The white peak 
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showed the negative control without any pDNA application and the gray peak showed the 
cells with polyplex application. The difference between the transfection of S2L-g-PEI30 (Figure 
40(a)) and S5L-g-TEPA28 (Figure 40 (b)) is not only the number of the transfected cells but 
also the fluorescence intensity of the transfected cells. The transfected cells by S5L-g-TEPA28 
polyplex showed much higher fluorescence intensity and a stronger peak shift to the direction 
of higher fluorescence intensity (Figure 40(b)). In fact, there were almost no cells which 
showed fluorescence intensity of 1,000 in the S2L-g-PEI30 polyplex applied cells, on the other 
hand, there was even a small peak observed over the fluorescence intensity of 1,000 in the 
S5L-g-TEPA28 polyplex treated cells (Figure 40(c)). Taken together, the S5L-g-TEPA28 has 
advantages in transfection not only the number of transfected cells but also in the total amount 
of the produced proteins. 
 
 
Figure 40: Histograms from Flow cytometry experiment in A549 cells. White peak: 
negative control. Gray peaks: polyplexes applied cells. (a) S2L-g-PEI30 polyplex, (b) 
S5L-g-TEPA28 polyplex, (c) stagger offset of S2L-g-PEI30 (middle) and S5L-g-TEPA28 
(front) polyplex 
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6.3.4 Agarose gel electrophoresis 
To study the DNA binding and condensation ability of each polyplex, agarose gel 
electrophoresis was done. In Figure 41, no pDNA could run through the gels without the 
addition of heparin (a, b, c, d and e), that indicated the perfect polyplexes formation without 
any free pDNA remaining. By the addition of an excess of heparin (samples marked with an 
apostrophe), all the pDNA-polymer complexes were broken and the released pDNA ran 
through the agarose gel. The pDNA band was made visible by ethidium bromide staining and 
it was thus possible to estimate the amount of pDNA in each polyplex was equal. 
Though all the polyplexes contained the same amount of pDNA, fluorescence intensity from 
the various polyplexes was different. The fluorescence intensity was attributed to the 
condensing, i.e. the tightness of the packing. (c) S5L-g-DETA24 showed the strongest 
fluorescence intensity, which represented the weakest DNA condensation ability of these 
polyplexes. This weak DNA condensation ability resulting in larger polyplex sizes, as is 
shown in Table 10, and it could be one of the reasons of the poor transfection efficiency of this 
sample. The strongest DNA-condensing (tight packing) ability was observed in (a) S2L-g-
PEI30 and (e) S5L-g-TREN28, and the middle were (b) S4L-g-TEPA24 and (d) S5L-g-TEPA28. 
TREN seemed to condense pDNA very strong, this result again fit very well with small size of 
the polyplex shown in Table 10. 
As is obvious from the results of transfection experiment and agarose gel electrophoresis, it is 
not always the case that the higher DNA condensation ability leads to higher transfection. 
Polymers with too strong DNA condensation ability might have disadvantage to release the 
DNA once inside the cytoplasma. 
Another interesting finding was the similarity of the two polyplexes from (a) S2L-g-PEI30 and 
(e) S5L-g-TREN28. The size, zeta-potential, and also the DNA condensation ability of these 
polyplexes were quite similar, though S2L-g-PEI30 showed good and S5L-g-TREN28 showed 
poor transfection efficiency. To find the dissimilarity of these two polyplexes, further studies 
have been done in the following part. 
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Figure 41: Agarose gel electrophoresis of polyplexes from different polymers  
M: size marker, pDNA: non-complexed plasmid (a) S2L-g-PEI30 N/P14, (b) S4L-g-
TEPA24 N/P18, (c) S5L-g-DETA24 N/P18, (d) S5L-g-TEPA28 N/P18, (e) S5L-g-
TREN28 N/P18, Character with apostrophe indicate the sample  after the addition of 5 
unit heparin 
 
 
6.3.5 Endosome buffering capacity measurements 
Endosome buffering capacity is one of the most important parameters of gene delivery vectors 
since it indicates the possibility of efficient endosomal escape. For example, b-PEI is well 
known to have high buffering capacity at acidic endosomal pH, known as “proton sponge 
effect”17.  
Through the acid-base titration, the endosome buffering capacities of different oligoamine side 
chains and b-PEI was studied. In Figure 42, the acid-base titration curves of each material are 
shown. The gray area is the endosomal pH-range, 7.4 to 5.1. Additionally, the amount of HCl 
needed for titration from pH 7.4 to 5.1 and the calculated buffering capacities were 
summarized in Table 11. As is obvious from Figure 42, the three oligoamine side chains 
showed quite different acid-base titration curves. The titration curve of TEPA is most similar 
to those of s-PEI and b-PEI. The pH change of the TEPA in the pH-range of 7.4 to 5.1 is the 
slowest of the three oligoamine side chains, which corresponds to the higher buffering 
capacity (15 %) compared to the other two oligoamines (Table 11).  
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This difference of buffering capacity between TEPA and the other two side chains could 
explain the difference in transfection efficiency. Especially, the characteristics of two 
polyplexes from S5L-g-TEPA28 and S5L-g-TREN28 were quite similar (Table 10), though 
showed completely different transfection efficiency (Figure 37). It is likely that, the 
characteristics of these polyplexes (size, zeta-potential and PDI) were preferable for the uptake, 
however the lower buffering capacity of TREN in the endosomal pH did not allow the same 
efficient endosomal escape. In combination with lower release by higher condensation that 
induced the much lower transfection efficiency compared to the TEPA grafted starch. In 
conclusion, TEPA is the most competent side chain of the three small MW side chains from 
the view point of buffering capacity and following endosomal escape. This low buffering 
capacity of TREN could also explain the difference in transfection efficiency compared to 
S2L-g-PEI30, though polyplex from S2L-g-PEI30 and S5L-g-TREN28 showed the similar size, 
PDI, zeta potential and DNA-binding ability. 
Despite the lower buffering capacity of TEPA than s-PEI, S4L-g-TEPA24 and S5L-g-TEPA28 
showed higher transfection efficiency than S2L-g-PEI30. This fact indicated that the buffering 
capacity of TEPA (15 %) is enough to escape from endosome, and not only the high buffering 
capacity is the required parameter for high transfection efficiency. Gabrielson et al.
126
 claimed 
that, the gene delivery activity could be attributable to an appropriate balance between 
polymer buffering capacity and strength of polymer/DNA interactions. Referring that, S2L-g-
PEI30 was assumed to have good buffering capacity, but not to have appropriate strength of 
polymer/DNA interactions. Since s-PEI has many amine groups, the interaction between 
polymer/DNA was extremely strong, and could not release the DNA effectively compared to 
the S5L-g-TEPA28. This strong DNA-binding ability of S2L-g-PEI30 was also observed in the 
agarose gel electrophoresis (Figure 41). The S5L-g-TEPA28 is assumed to have an appropriate 
balance of the buffering capacity and binding ability to the DNA, thus showed the superior 
transfection efficiency than S2L-g-PEI30. 
The buffering capacities of the synthesized polymers were also studied and summarized in 
Table 11. All polymers showed the increased buffering capacities compared to their side 
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chains by the conjugation with starch backbone, though the sequence of the buffering capacity 
was exactly equivalent to that was observed in the side chains. Starch-graft-TEPA showed its 
advantage in buffering capacity compared to other side chains, though it is still lower than 
starch-graft-PEI. This result fit with the discussion before in the buffering capacity of the side 
chains; not only is the high buffering capacity the required parameter for high transfection 
efficiency. 
 
 
Figure 42: Acid-base titration of different side chains and b-PEI. The gray area is pH-
range of 7.4 to 5.1. 
 
 
Table 11: Calculated buffering capacities of each side chains, synthesized polymers 
and b-PEI, in the pH-range of 7.4 to 5.1  
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6.3.6 Cytoxicity 
The cytotoxicity of the S4L-g-TEPA24 and S5L-g-TEPA28 and was studied with MTT assay. As 
is shown in Figure 43 (a) S4L-g-TEPA24 and (b) S5L-g-TEPA28, both polymers showed almost 
no cytotoxicity (almost 100 % cell viability), in the concentration needed for optimal 
transfection (gray area). As a comparison, the cytotoxicity of PEI 25 kDa and S2L-g-PEI30 is 
also shown in the same graph. The cytotoxicity of S2L-g-PEI30 was lower than PEI 25 kDa, but 
higher than the both polymers with TEPA side chains, S4L-g-TEPA24 and S5L-g-TEPA28. 
These results are a clear evidence of the superior competency of S4L-g-TEPA24 and S5L-g-
TEPA28 to S2L-g-PEI30 and PEI 25 kDa as gene delivery vectors, in terms of gene delivery 
efficiency and also safety. 
Surprisingly, the cytotoxicity of the S4L-g-TEPA24 and S5L-g-TEPA28 were further decreased 
after the 3 h incubation with α-amylase, as is observed with S2L-g-PEI30 in chapter 4. The 
decreasing of the cytotoxicity was not expected, since the starch backbone of S4L-g-TEPA24 
and S5L-g-TEPA28 were highly modified with TEPA side chains compared to the S2L-g-PEI30. 
However, this decreased cytotoxicity obviously indicated the degradation of those polymers 
by α-amylase. Thus a further biodegradability study of the synthesized polymers has been 
done in the following experiments. 
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Figure 43: Results of the MTT cytotoxicity tests (A549 cells).  
The gray area shows the concentration needed for the best transfection efficiency. 
(a) S4L-g-TEPA24 transfection reagents (b) S5L-g-TEPA28 transfection reagents  
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6.3.7 Biodegradability study by α-amylase 
The biodegradability of S4L-g-TEPA24 and S5L-g-TEPA28 was studied by α-amylase using an 
iodine-based method. In Figure 44, incubation time with α-amylase vs. the absorbance at 580 
nm from starch-iodine complex can be seen. The amount of the α-amylase was adjusted for 
each sample in order to see the time dependent degradation. 10 µunit of α-amylase for S4L-g-
TEPA24 and 1 µunit for S5L-g-TEPA28 was used for each well. 
 
 
 
Figure 44: Biodegradability by α-Amylase over 90 min, 37 °C 
 
 
It is known that α-amylase is less effective in degrading modified starches because of the 
molecular specificity of the enzymatic reaction. It was therefore not expected that the 
synthesized cationic starch polymers with high modification amount maintained enzymatic 
degradability. Compared with S2L-g-PEI30, S4L-g-TEPA24 and S5L-g-TEPA28 were much more 
modified with side chains. Every 3.7th glucose of S4L-g-TEPA24 and every 2.9th glucose of 
S5L-g-TEPA28 carries one TEPA side chain, on the other hand, every 12.6th glucose of S2L-g-
PEI30 carries one s-PEI side chain.  
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In Figure 44, contrary to what we expected, the absorbance at 580 nm which corresponds to 
the amount of the starch-iodine complex was decreased over 90 min by incubation with α-
amylase. These results are the clear evidence of the degradation of S4L-g-TEPA24 and S5L-g-
TEPA28 by α-amylase. And these results were also supported by the reduced cytotoxicity of 
the MTT test (Figure 43). Unfortunately, the degradation rate cannot be compared to original 
starch or starch-g-PEI, even between S4L-g-TEPA24 and S5L-g-TEPA28, since the amount of α-
amylase was optimized for each sample. However the fact of remaining biodegradability 
should be a huge benefit in respect of the safety issue as gene delivery vector.  
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6.4 Conclusion 
 
The starch based cationic polymers modified with oligoamine side chains could form nano-
sized polyplexes with pDNA, some of which showed a very promising transfection efficiency 
in the A549 cell line. Successful transfection was observed both qualitatively and 
quantitatively, by the luciferase assay and by flow cytometry analysis of fluorescent protein-
expressing cells. The transfection efficiency was seen to depend on the MW and the structure 
of the side chains. The best transfection efficiency was observed from the starch based 
cationic polymer which had 28 wt% of TEPA side chains. The observed transfection 
efficiency was much higher than all three positive controls, commercial transfection reagent 
jetPRIME
TM 
 used as recommended in the manufacturer's protocol, PEI 25 kDa, and our best 
starch-g-PEI, S2L-g-PEI30. 
Furthermore, we demonstrated a lower cytotoxicity of S4L-g-TEPA24 and S5L-g-TEPA28 than 
S2L-g-PEI30 and PEI 25 kDa. After the incubation with α-amylase, the cytotoxicity of 
synthesized starch-g-TEPA polymer was even further decreased. This implied that the starch 
backbone of the modified polymer was degraded and became almost non-toxic small 
fragments. By iodine-starch assay, the degradation of the S4L-g-TEPA24 and S5L-g-TEPA28 
was confirmed. 
In conclusion, we have successfully developed the starch based cationic polymers, which 
could achieve a superior transfection efficiency and safety (low cytotoxicity and 
biodegradability). 
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7 Summary and outlook 
 
The aim of presented work was to design biodegradable starch based cationic polymers and 
evaluate their potential as non-viral gene delivery vector. In this context, it was demonstrated 
that a simple and reproducible method to synthesize starch based cationic polymers with 
various kinds of side chains was successfully established. By use of DMTMM reaction reagent, 
the conjugation reaction proceeded satisfactorily in co-solvent H2O / DMSO. The advantages 
of the DMTMM reagent are; 1) it works in the presence of water, 2) the mild reaction 
condition in R.T., 3) easy handling (white powder) and 4) easy purification method by 
washing with water. (chapter 3). 
 
Additionally, it was shown that several synthesized polymers had promising potential as gene 
delivery vectors with respect to efficiency and safety by precisely controlled polymer design. 
Namely, it was shown that starch-g-PEI polymer required around 30 wt% PEI modification 
and large MW (> 550,000 g/mol) for optimal transfection efficiency. These well designed 
starch-g-PEI polymers showed higher transfection efficiency and lower cytotoxicity than 
positive control PEI 25 kDa, and retaining the biodegradability by α-amylase. (chapter 4) 
 
Hydrophobic modification onto the starch-g-PEI polymer had been done in chapter 5. Due to 
the introduction of hydrophobic groups, the DNA-binding ability decreased slightly, that 
brought the significant decrease of transfection efficiency, though polyplex characteristics 
(size, PDI and zeta-potential) were almost same. The presence of only few hydrophobic 
groups was enough to show this effect. These results demonstrated the great importance of the 
precise design of polymers, and only a small change on the polymer could change 
dramatically the ability of the polymer as gene delivery vector. 
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Furthermore, it was demonstrated that the TEPA cationic side chain brought even more 
advantage than s-PEI side chain. Starch-g-TEPA with around 30 wt% side chain modification 
showed the similar polyplex characteristics (size, PDI and zeta-potential) as that of starch-g-
PEI, but superior results in transfection efficiency and cytotoxicity, at the same time, retaining 
the biodegradability by α-amylase. (chapter 6) 
 
In summary, these results underline that well designed starch based cationic polymers would 
be promising candidates as non-viral gene delivery vector, and only a little modification could 
drastically alter their ability. For realizing an ideal polymer, suitable valance of every property 
would be required, for instance, MW, amount of cationic charges, DNA-binding/-release 
ability, and endosome buffering capacity.  
 
 
However, it should be emphasized that here presented works are just early-stage studies of 
starch based cationic polymers as gene delivery vector. Although this thesis as a piece might 
contribute to the establishment of a simple and reproducible starch modification method and 
better understanding on the essential properties of polymers, still several open questions are 
raised. 
 Regarding the hydrophobic modifications, the increased cytotoxicity and decreased DNA-
binding ability was a critical factor in chapter 5. Yet, several researchers reported the 
increasing transfection efficiency by the introduction of hydrophobic groups. Thus, it 
would be a great of interest to find out the key parameter of the hydrophobic groups to 
give a positive or negative effect to gene delivery systems. 
 In this thesis, four different cationic side chains were tested to modify starch backbone 
and studied the effect of the different side chains to the starch-graft-cationic polymers as 
gene delivery vectors (Chapter 4 and Chapter 6). However, there are much more possible 
cationic side chains that could provide satisfactory properties to starch backbone. It would 
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be definitely interesting to do a screening test of the buffering capacity of different 
cationic molecules to find out the promising candidates as cationic side chains.  
 With respect to the practical applications, in vivo experiments are prerequisite. All studies 
performed in this thesis were based on in vitro and further experiments using different 
type of cells are needed to find out the appropriate practical applications and in vivo 
studies. 
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List of abbreviations 
 
Benz-ITC benzyl isothiocyanate  
b-PEI branched-polyethyleneimine 
CD cyclodextrine 
CDMT 2-chloro-4,6-dimethoxy-1,3,5-triazine 
CLSM confocal laser scanning microscopy 
CME clathrin-dependent endocytosis 
CNT carbon nanotubes 
CycHex-ITC cyclohexylmethyl isothiocyanate 
DCC N,N'-dicyclohexylcarbodiimide 
DCChol 3β(N-(N,N-dimethylaminoethane)-carbamoyl) cholesterol  
DETA dietylenetriamine 
DMAEMA 2-(dimethylamino)ethyl methacrylate 
DMSO dimethyl sulfoxide 
DMTMM 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4methyl-morpholinium 
chloride 
DOGS dioctadecylamidoglycylspermine 
DOPE Dioleoylphosphatidylethanolamine 
DOTAP 1,2-bis(oleoyloxy)-3-(trimethylammonio)propane 
DOTMA N-(1-(2,3-dioleyloxy)propyl)-N,N,N-trimethylammonium 
chloride 
DS degree of substitution 
EDA ethylenediamine 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EGMA ethylene glycol methacrylate 
EPR effect Enhanced Permeation and Retention effect 
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FBS fetal bovine serum 
FT-IR fourier transform infrared spectroscopy 
-g- -graft- 
GPC gel permeation chromatography 
GTP guanosine triphosphate 
HBSS Hank's balanced salt solution 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
Hep-IC heptyl isocyanate 
HES hydroxyethyl starch 
HOBt hydroxybenzotriazole 
IC isocyanate 
ITC isothiocyanate 
LDH lactate dehydrogenase 
l-PEI linear-polyethyleneimine 
MMA methyl methacrylate 
MR  magnetic resonance 
MRI magnetic resonance imaging 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid 
MW molecular weight 
NMM 4-methylmorpholine  
NMR nuclear magnetic resonance 
NHS N-hydroxysuccinimide 
NVP N-vinylpyrrolidone 
PAMAM polyamidoamine 
PBS phosphate buffered saline 
PCL polycarprolactone 
PCI Photochemical internalization 
PD polydispersity 
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PDI polydispersity index 
pDNA plasmid DNA 
PEG polyethylene glycol 
PEHA pentaethylenehexamine  
PEI polyethyleneimine 
PLGA Poly(lactid-co-glycolid) acid 
PLL Poly(L-lysine) 
PPI Poly(propylenimine) 
RAFT reversible addition−fragmentation chain transfer 
RGD arginine-glycine-aspartic acid 
RLU relative light units 
TBE Tris/Borate/EDTA 
TEMPO 2,2,6,6-tetramethyl-1-piperridinyloxy 
TEPA tetraethylenepentamine 
TETA triethylenetetramine 
THF tetrahydrofuran 
TREN tris(2-aminoethyl)amine 
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